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Aleutian disease (AD) is a common global disease in farmed mink caused by infection 
with Aleutian disease virus (ADV). This thesis investigated the use of ADV antibody 
ELISA as a tool to reduce the impact on welfare and reproduction of mink in ADV 
endemic areas. First, two ELISA systems were compared. The ELISA system based on 
VP2 antigen detected ADV antibodies in serum with high sensitivity and specificity 
when compared to counter immunoelectrophoresis (CIEP). In contrast, the ELISA 
system based on ADV-G antigen did not perform as well and had a low sensitivity 
compared to CIEP. The VP2 ELISA also detected antibodies to ADV in dried whole 
blood eluted from filter paper (DBS) with a preserved high sensitivity and specificity and 
with good correlation to antibody levels in serum. The ADV antibody levels were 
comparable over a period of two weeks which may correspond to the time needed to 
sample all mink in large herds.  
The correlation between the estimated antibody level in DBS and the ratio of albumin: 
gamma globulins (A:γG) in serum in individual mink was generally high but superior for 
DBS compared to serum samples from the same mink. The use of DBS VP2 ELISA was 
therefore concluded to be the preferable indirect method for estimating 
hypergammaglobulinemia in mink. Further, the association between the reproductive 
performance and the antibody level was also investigated at an individual level. For the 
primiparous mink, the risk of being barren was associated with the AD status prior to 
mating. Diseased mink had a higher risk of being barren than non-diseased mink. In 
addition, the litter size of the primiparous non-barren female mink was also associated 
with the AD status prior to mating, where diseased mink had a 5% reduced litter size. 
For older mink, on the other hand, no difference due to AD status was found but they had 
approximately 5 % larger litters than primiparous mink irrespective of AD status.  
To aid selection of future breeders, the female mink could be categorized into two or 
three different disease categories depending on the mean antibody level in the herd. 
Selection of healthy mink for breeding can be expected to be beneficial for the welfare 
of the female mink, the overall breeding performance of the herd, as well as the 
production economy.  
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1.1 Mink production 
Mink, Neovison vison, have been held for pelt production since the early 20th 
century (Joergensen, 1985b) and today, more than 50 million skins are produced 
in the world each year (Kopenhagen Fur, 2016; Fur Europe, 2015). The largest 
mink producing countries in the world are Denmark, Poland, the Netherlands 
and China, and together they account for approximately two thirds of the total 
global production (Fur Europe, 2015). In Sweden, the production is relatively 
small and in 2015, the number of breeding female mink were approximately 170 
000 and about 1 million pelts were produced (Svensk Mink, 2016; Svensk Mink, 
2015). There are today around 50 mink herds in Sweden, all located in the 
Southern parts of Sweden and with most farms situated at Listerlandet, Blekinge, 
and around Skara, Västra Götaland (Svensk Mink, 2017) (Figure 1).  
All mink are kept in wire netting cages with an adjacent nest box. From 
weaning, juvenile mink are kept in small groups and before the time for sexual 
maturity, they are moved into separate cages. Thereafter, adult mink only share 
cage during mating (Fur Europe / European Fur Breeders' Association, 2015; 
Joergensen, 1985a). In contrast to many other farm animals, mink production in 
general is completely integrated and the complete cycle takes place at the same 
farm (Fur Europe / European Fur Breeders' Association, 2015). Consequently, 
the number of animals in a herd varies greatly during the year (Fur Europe / 
European Fur Breeders' Association, 2015).  
 
1 Background 
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Figure 1. Areas in Sweden where mink herds are primarily located 
The production year at a mink herd (Figure 2) is highly predictable since the 
reproduction in mink is strictly seasonal (Murphy, 1992; Hansson, 1947). The 
breeding season starts with mating in early March (early spring in the Northern 
hemisphere) and gestation ends with parturition in late April/early May. At eight 
weeks of age (late June/early July), the mink kits are weaned and moved two 
and two into new cages. During the summer, the mink kits grow rapidly and in 
September, they have reached full body length. Thereafter, the winter fur 
develops and in October, breeding animals for the next season are selected while 
the remaining mink are pelted during November and December (Joergensen, 
1985a). 
The key to success in mink production is to produce a maximum number of 
large, high quality pelts of a, by the market, desirable colour (Joergensen, 
1985b). Hereditary characteristics, in combination with welfare of the animals 
as well as environmental factors such as climate, feed, hygiene and management, 
will determine the net production (Joergensen, 1985b). Selection of breeding 
animals is primarily focused on resistance to disease, reproductive performance 
and different fur characteristics (Joergensen, 1985b). The past decades, welfare 
of the animals has rendered more and more focus (Fur Europe / European Fur 
Breeders' Association, 2015).  
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Figure 2. The production year at a mink herd 
1.2 The farmed mink 
The farmed mink (Neovison vison) originates from several subspecies of the 
North American mink (Nes, 1988; Shackelford, 1957). Originally, the farmed 
mink had dark brown coat colour and larger areas with white fur were not 
uncommon (Nes, 1988). In 1931, a new mink colour type evolved due to gene 
mutation and was named Silver blue (Nes, 1988). With time, an array of different 
dominant and recessive gene mutations has resulted in the wide variety of mink 
colour types that exist today (Nes, 1988).  
Each colour type mutation has its own positive and negative characteristics. 
For instance, one of the recessive gene mutations, the Aleutian gene, will in 
homozygous mink not only lead to a dark blue coat colour but also to 
development of Chediak-Higashi syndrome (Nes, 1988). This syndrome is 
characterized by a leukocyte defect leading to for instance immunodepression 
(Nes, 1988). Hedlund white mink, on the other hand, are born deaf leading to a 
calmer mink but with risk of impaired maternal ability due to impaired kit – 
female vocal communication (Nes, 1988; Joergensen, 1985b). The choice of 
colour distribution in the herd is highly specific for each farmer but often the 
aims are to allow for both market trends and long-term stability which will 
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decrease the economic risk and enable genetic progress at the same time 
(Joergensen, 1985b). 
1.3 Mink reproduction 
1.3.1 General description 
Since mink are housed under the influence of natural light and the reproductive 
cycle is dependent on the day length, reproduction in mink is strictly seasonal 
(Murphy, 1992; Hansson, 1947). In the Northern hemisphere, female mink 
accept to be mated during approximately the first three weeks of March 
(Murphy, 1992). Ovulation of the female mink is induced by mating, and take 
place within three days after mating (Lagerkvist, 1992; Sundqvist et al., 1989). 
After ovulation, the oocysts are transported to the oviduct where the fertilization 
takes place. The fertilized ova then develops into blastocysts that reach the uterus 
within a week after mating (Lagerkvist, 1992; Hansson, 1947). The embryo 
development then ceases and the blastocysts float around freely in the uterus 
during what is called the embryonic diapause (Lopes et al., 2004; Sundqvist et 
al., 1989). The actual length of the embryonic diapause is not fixed but is 
determined mainly by the increasing day length (Lopes et al., 2004; Allais & 
Martinet, 1978; Murphy & James, 1974). It is the change in day length associated 
with the vernal equinox in the Northern hemisphere which leads to hormonal 
changes of the female mink and initiates the delayed embryo implantation 
(Lefevre et al., 2011; Desmarais et al., 2004; Lopes et al., 2004; Murphy et al., 
1981).  
Interestingly, this embryonic diapause and the delayed embryo implantation 
enable mink to have a second ovulation before implantation. A new set of 
follicles develop within a week after the first ovulation and these follicles will 
also ovulate if the female mink is re-mated (Lagerkvist, 1992; Murphy, 1992). 
For this reason, female mink can give birth to kits from different ovulations 
(superfetation) (Shackelford, 1952). At the time of such a second mating 7-8 
days after the first mating (“1+8 or 1+9 system”), the first set of embryos are 
floating free in the uterus and the second set of embryos will join the first set of 
embryos in the uterus. Studies have shown that the relative contribution to the 
litter born is higher for the second compared to the first mating (Murphy, 1996; 
Lagerkvist, 1992). An alternative way of repeated mating worth mentioning is 
mating on two consecutive days (“1+1 system”). Here the first mating will 
induce ovulation but due to the delay of a couple of days until the ovulation 
occurs, the second mating will also occur prior to the arrival of ova to the 
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oviduct. The ova can therefore be fertilized by sperm from both matings 
(superfecundation) (Murphy, 1996; Einarsson, 1992; Lagerkvist, 1992) 
Parturition occurs 30±3 days after implantation (late April and the beginning 
of May) (Murphy, 1992; Hansson, 1947). The female mink usually give birth to 
a litter between one to 12 kits (Svensk Mink, 2017) but unfortunately, some 
female mink will not give birth (i.e. barren females). In Sweden, the mean 
number of kits born per mated female mink for the years 2012-2016 was 4.8 – 
5.1 and the mean percentage of barren females was 8 – 12% (Svensk Mink, 
2017).  
1.3.2 Factors associated with reproductive performance 
Reproductive performance of the female mink can be expressed in terms of 
percentage of barren females and/or litter size at different times post-partum 
(e.g. at birth, three weeks post-partum, six weeks post-partum, at weaning or at 
pelting). Due to kit mortality, this will influence the reported reproductive 
performance (Svensk Mink, 2017; Joergensen, 1985b) and needs to be taken into 
account when comparing different studies. In addition, the number of kits born 
per mated female mink can be reported even though this is a joint measure of 
two separate processes i.e. being barren and litter size of non-barren female 
mink. This further complicates comparisons between different studies but some 
general factors that have been shown to affect the net reproductive performance 
are the genetic predisposition, presence of disease, age of the female mink, 
nutrition and feeding as well as mating regimes. 
Genetic predisposition 
There are many different sub-traits involved in reproductive performance where 
litter size is a commonly used trait in genetic selection for better reproductive 
performance. The heritability for litter size in mink is approximately 0.1 – 0.2 
(Hansen et al., 2010; Einarsson, 1992). Different genetic lines of mink (colour 
types, for instance) can therefore differ in reproductive performance (Seremak, 
2013; Brzozowski et al., 2012; Dziadosz, 2010; Felska & Sulik, 2000), and 
intentional or unintentional inbreeding can lead to differences in reproductive 
performance (Demontis et al., 2011; Berg, 1996). 
Diseases 
Diseases can negatively affect the reproductive organs and have a detrimental 
effect on the female reproductive performance. Abortions and death of neonatal 
kits due to infections with Campylobacter jejuni, Salmonella Dublin, and 
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Toxoplasma gondii have been described (Dietz et al., 2006; Frank, 2001; Hunter 
et al., 1983). Another important disease which can have a significant impact on 
the reproductive performance is Aleutian disease (AD) (Hansen & Lund, 1988; 
Kangas & Smeds, 1983).  
Age 
Reports of the effect of age on reproduction have not been consistent. Some 
reports have indicated that two-year-old female mink have the best reproductive 
performance in terms of kits per mated female mink as well as litter size, and 
that the reproductive performance decreases from the third litter (Tauson, 1985; 
Venge, 1973; Hansson, 1947). Another study reported no significant difference 
between primiparous and two-year old female mink, but a decreased number of 
live kits born from the age of three years (Dziadosz, 2010). In addition, that study 
reported that the primiparous mink had the highest number of live born kits for 
some of the colour types (Dziadosz, 2010). This highlights the idea that the 
various factors most likely interact and together influence the reproductive 
performance of the mink (Dziadosz, 2010; Tauson, 1985) 
Nutrition and feeding 
Nutritional factors that can have an effect on the reproductive performance 
include the amount of nutrients (Matthiesen & Tauson, 2015; Matthiesen et al., 
2010; Tauson, 1992; Helgebostad, 1980), the energy supply/female body 
condition (Tauson, 1985), the hygienic quality and the chemical quality of the 
feed (Juokslahti, 1980; Moeller & Nordstoga, 1978; Jarosz & Barteczko, 1976). 
In addition, feeding regimes can play a role and strategic flushing just before 
mating has been reported to be positively associated with an increased litter size 
in both primiparous and older female mink (Tauson, 1992; Tauson, 1985).  
Mating regimes 
Knowledge about the reproduction physiology of the female mink is strongly 
reflected in the mating regimes practiced with purpose of maximizing the 
number of kits. Mating only once is known to result in an inferior reproductive 
performance compared to repeated matings (Lagerkvist, 1992; Venge, 1973). 
The most commonly used repeated mating system is mating 7-8 days after the 
first mating (the 1+8 or 1+9 system) which has been reported to improve the net 
number of kits compared to both single matings, as well as mating on two 
consecutive days (the 1+1 system (Murphy, 1996; Tauson, 1985; Venge, 1973)). 
In addition, with the aim of further maximizing the net number of kits born, a 
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combination of the above two repeated mating systems where mink are allowed 
to mate twice with 6-7 days apart and then thirdly one day after the second 
mating has been practiced (Murphy, 1996; Venge, 1973). However, recent 
publications have presented contradictory results where the highest number of 
kits weaned was documented for female mink mated twice with an interval 
between the first and the second mating between one and four days (Ślaska & 
Rozempolska-Rucińska, 2011). Being aware that this contradicted most 
previous publications, the authors concluded that other factors than the mating 
system probably also contributed to the reproductive performance. Such factors 
could include date of first mating, colour type and age which all had previously 
been demonstrated to have an effect on the reproductive performance (Ślaska & 
Rozempolska-Rucińska, 2011). Though, for the scope of this thesis, it is enough 
to conclude that management around mating can influence the reproductive 
performance.  
1.4 Aleutian disease in mink 
Infection with Carnivore Amdoparvovirus 1 cause AD in mink and other 
mustelids worldwide (Farid & Rupasinghe, 2016; Porter et al., 1982). A 
complex interaction between the virus and the immune system of the mink 
causes an immune complex mediated disease with diffuse symptoms such as 
inappetence, impaired growth, and reduced reproductive performance 
(Reichert & Kostro, 2014; Hansen & Lund, 1988; Eklund et al., 1968). At 
farm level, AD can have a significant negative impact on both animal welfare 
and production economy. It has been estimated that the loss of kits due to 
AD until weaning is up to 1 kit per litter (Kangas & Smeds, 1983) while the 
mortality from weaning to pelting is slightly increased in AD seropositive 
herds compared to AD seronegative herds (Svensk Mink, 2017; De Rond. & 
Kleyn Van Willigen, 2012). Translating this into economic terms, a pelted 
mink represented in average approximately 20 € in 2015-2016 (Saga Furs 
Oyj, 2016) leading to an estimated production loss of up to 50,000 € per year 
due to AD for an average Swedish farmer with 2,500 female mink. 
Currently there is no treatment for the disease and traditionally in countries 
where AD is less prevalent and the pathogen load is low to moderate, stamping 
out has been used to control AD (Cho & Greenfield, 1978). Stamping out has, 
however, been less successful in areas where AD is highly prevalent and the 
pathogen load is high (Themudo et al., 2011). In countries with endemic AD, 
the focus has instead shifted towards the idea that some individuals seem to be 
more resistant to development of clinical disease with the aim to develop 
strategies to control the negative impact of AD (Thomsen, 2016; Farid & 
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Segervall, 2014). Every year, in conjunction with pelting and/or prior to the 
breeding season, all mink are screened for AD usually one to three times (Svensk 
Mink, 2017) to ensure that no clinically diseased animals are bred. 
1.4.1 Characteristics of Carnivore amdoparvovirus 1  
The Carnivore Amdoparvovirus 1, formerly known as Aleutian Disease Virus 
(ADV)1, is a small, non-enveloped DNA virus belonging to the genus 
Amdoparvovirus, subfamily Parvovirinae and family Parvoviridae (Canuti et al., 
2015; Cotmore et al., 2014; International Committee on Taxonomy of Viruses) 
(Figure 3). Many different strains of ADV have been described (Alexandersen 
et al., 1994; Aasted et al., 1984a) and often multiple strains can be detected 
within a herd as well as within an individual mink (Olofsson et al., 1999; 
Gottschalck et al., 1994; Hadlow et al., 1984)  
The ADV genome encodes for two capsid viral proteins (VP) and three non-
structural (NS) proteins (Huang et al., 2014; Qiu et al., 2007; Qiu et al., 2006). 
The capsid proteins VP1 and VP2 form the nucleocapsid together with the 
genome (Quinn et al., 2011; Lodish H, 2000). By binding to receptor proteins 
on the host cells, they initiate the infection process (Lodish H, 2000) and this 
interaction also determines the pathogenicity, host range and cellular tropism of 
ADV (Kontou et al., 2005; Lodish H, 2000; McKenna et al., 1999). Moreover, 
it has been suggested that it is one part of the VP2 which is essential for the 
immune complex formation typical to AD (Bloom et al., 2001). The NS proteins, 
on the other hand, are not a part of the virus itself. They are instead coded for by 
the viral genome, expressed in the infected host cells and involved in various 
processes associated with the replication of the virus (Huang et al., 2014; 
Uversky & Longhi, 2011; Bloom et al., 1982).  
 
                                                        
1 In lack of a well-established abbreviation, the carnivore amdoparvovirus 1 will be referred to 
as ADV in this thesis for simplicity and in order to avoid confusion even though the taxonomy has 
been revised. 
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Figure 3. Members of the virus family Parvoviridae (Canuti et al., 2015; Cotmore et al., 2014; 
International Committee on Taxonomy of Viruses) 
1.4.2 Transmission of virus  
As seen in Figure 4, ADV can spread both horizontally (Jackson et al., 1996; 
Gorham et al., 1976; Gorham et al., 1964; Kenyon et al., 1963) and vertically 
(Broll & Alexandersen, 1996; Gorham et al., 1976; Henson et al., 1976; Padgett 
et al., 1967a). Depending on the virus strain and genotype of the mink, the rate 
of transmission will vary (Oie et al., 1996; Gorham et al., 1976; Gorham et al., 
1964).  
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Figure 4. ADV transmission routes within a mink herd: Vertical transmission between the female 
mink and her kits or horizontal transmission either direct or indirect from one mink to another2. 
1.4.3 The immune response upon infection with ADV 
When an individual is infected with a virus, the innate immune system normally 
induce the initial protection through recognition and killing of the invading 
microorganism e.g. by phagocytosis and apoptosis by neutrophils, macrophages 
and natural killer (NK) cells (Abbas et al., 2012; Tizard, 2012a). In addition, 
signals are sent to the adaptive immune system (Abbas et al., 2012) where the 
cell-mediated adaptive immune system works through different T cell mediated 
activities (Abbas et al., 2012). An infected host cell presents foreign peptides 
(antigens) via the major histocompatibility complex (MHC) proteins on the cell 
surface and this activates the cytotoxic T cells which then will destruct the 
infected cell by either cell lysis or apoptosis (Abbas et al., 2012). 
With time, the humoral immune response develops where the antimicrobial 
activity instead is mediated by antibodies produced by plasma cells originating 
from the B cells (Abbas et al., 2012). Viral antigens bind to the B cell receptors 
(BCR) leading to selection of the clones of immature B cells with the appropriate 
BCR (clonal selection) and the selected clones begin to divide repeatedly 
(polyclonal expansion) (Abbas et al., 2012; Tizard, 2012a). The B cells then 
develop further into plasma cells (differentiation) resulting in an increased 
concentration of antigen specific antibodies. Initially, the antibodies produced 
                                                        
2 Illustration by: Anna-Maria Andersson with graphical contributions as follows: “Mink” icon 
from Anna Bearne, “feces” icon from Douglas Santos, “cage” icon by corpus celicti, “glove” icon 
by Dolly Vu and “roast chicken” icon from Emilegraphics – all from the Noun Project, 
thennounproject.com 
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by plasma cells are of IgM type, but the production is switched to for instance 
IgG within a few days. Alternatively, the B cells can differentiate into memory 
cells which are essential for the immunological memory (Tizard, 2012a).  
In general, antibodies aid removal of the infection in four different ways 
(Abbas et al., 2012): (i) through neutralization where antibodies bind to 
circulating virus and thereby hinder entrance into the host cells, (ii) through 
opsonization where antibodies (or complement fragments) coat the viral 
particles and thereby enhance phagocytosis of the microorganism by neutrophils 
and macrophages, (iii) through antibody-dependent cellular cytotoxicity where 
antibodies bind to virus infected cells and thereby aid the lysis of these cells by 
cells of the innate immune system, and (iv) through activation of the complement 
system leading to both lysis of microorganisms and indirect enhancement of 
phagocytosis through opsonization.  
However, there are viruses that have evolved methods to resist the immune 
system. Such viruses manage to invade the host cells where they survive, 
replicate and further evade the immune system (Abbas et al., 2012). One 
example is ADV where the antibodies produced bind to the virus but fail to 
neutralize it. Instead, the entrance of ADV into the host cells is facilitated by the 
opsonization and Fc-receptor-mediated endocytosis (Tizard, 2012c; Bloom et 
al., 2001; Lodish H, 2000; Kanno et al., 1993). Once the virus has entered the 
host cells, the infection commonly becomes non-cytopathic due to an intricate 
mechanism (Knuuttila, 2015; Alexandersen et al., 1989; Alexandersen et al., 
1988; Hadlow et al., 1985; Eklund et al., 1968). Consequently, the virus 
becomes sequestered, has the possibility to replicate and can persist within the 
mink for a very long time (Knuuttila, 2015; Alexandersen et al., 1988; Porter, 
1986; Hadlow et al., 1985; Porter et al., 1980; Eklund et al., 1968).  
The incessant virus replication leads to a continuous stimulation of the 
humoral immune response, which in turn results in elevated levels of serum 
gamma globulin (hypergammaglobulinemia) and an accumulation of plasma 
cells in different organs (plasmacytosis) (Reichert & Kostro, 2014; Bloom et al., 
1994; Porter et al., 1980; Porter et al., 1969). At the same time, immune 
complexes are formed between viral antigens and antibodies that activates the 
complement system (Maclachlan & Dubovi, 2016; Tizard, 2012b). These 
immune complexes then circulate in the body and deposit in various tissues. In 
the tissues, deposition of a large amount of immune complexes and 
accompanying activated complement components attract neutrophils and lead to 
a severe inflammatory reaction called type III hypersensitivity reaction 
(Maclachlan & Dubovi, 2016; Tizard, 2012b). The severity of the 
hypersensitivity reaction depends on both the affected organ as well as the net 
amount of immune complexes and activated complement components (Tizard, 
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2012b). The pathological lesions due to ADV infection is therefore a result of a 
maladjusted host immune response to the virus rather than the virus infection 
itself (Porter, 1986), and the degree of tissue lesions has been shown to correlate 
to the degree of hypergammaglobulinemia (Kenyon et al., 1963). In mink with 
AD, organs such as kidneys, liver, spleen, bone marrow, uvea and arteries are 
subject to immune complex mediated tissue damage (Porter et al., 1980) leading 
to vasculitis (Tizard, 2012b; Porter et al., 1980; Porter et al., 1973), 
membranoproliferative glomerulonephritis (Tizard, 2012b; Alexandersen et al., 
1988; Porter et al., 1973; Henson et al., 1969), splenomegaly, hepatomegaly, 
lymphadenopathy, CNS and mucosal haemorrhages (Tizard, 2012b; Henson et 
al., 1976) (Figure 5). 
 
 
Figure 5. Pathological lesions associated with AD: Left: splenomegaly and petechial haemorrhages 
on the surface of the kidney. Upper middle & right: interstitial plasma cell infiltration of the renal 
cortex and mesangial thickening of the glomeruli [kidney]. Lower middle & right: plasma cell 
infiltration in the portal areas [liver]. Photo by SVA. 
The hypergammaglobulinemia in AD mink is essentially a consequence of 
an increased amount of specific ADV antibodies (Aasted & Bloom, 1984; Porter 
et al., 1984a; Henson et al., 1976; McGuire et al., 1971) produced against both 
structural and non-structural viral proteins (Costello et al., 1999; Aasted & 
Bloom, 1984; Bloom et al., 1982). However, estimations of the correlation 
between the amount of ADV specific antibodies and the 
hypergammaglobulinemia have shown varying results with correlation 
coefficients ranging from -0.39 to 0.82 (Cepica, 2016; Aasted & Bloom, 1984; 
Porter et al., 1984a). Part of these discrepancies can be due to differences in the 
different studies concerning the method to determine the serum proteins as well 
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as the method used for ADV antibody detection (Cepica, 2016; Aasted & Bloom, 
1984; Porter et al., 1984a). However, a lack of correlation between the ADV 
antibody levels and gamma globulin levels of an individual can, just as the 
clinical manifestation, also possibly be attributed to differences in virus strains 
and host factors. For instance, infection with highly pathogenic strains of ADV 
induce high levels of gamma globulins more rapidly than infections with less 
pathogenic strains (Knuuttila, 2015; Aasted & Bloom, 1984) and the correlation 
between the antibody level and the level of gamma globulins can then be 
expected to be high. The genotype of the mink can also play a role for the 
increase in gamma globulin levels (Johnson et al., 1975; Porter et al., 1973; 
Padgett et al., 1968; Padgett et al., 1967b). Moreover, during an ADV infection, 
B cell clones responding to other substances than ADV antigens are also 
expanding and antibodies to those substances are formed (Hahn & Hahn, 1983). 
Therefore, the gamma globulin levels can increase although the increase in ADV 
antibody level has levelled out (Bloom et al., 1994; Bloom et al., 1975). An 
example is autoantibodies to DNA which can be detected in both normal and 
infected mink but at higher concentrations in AD mink (Hahn & Kenyon, 1980; 
Barnett et al., 1969). The amount of autoantibodies has been reported to be 
proportional to the amount of serum gamma globulins in adult mink with AD 
(Aasted et al., 1984b; Porter et al., 1980; Porter et al., 1965a; Henson et al., 
1961). 
1.4.4 Pathogenesis of disease and clinical manifestations  
The general target cells for parvovirus infections are actively dividing cells since 
parvoviruses are dependent upon the S-phase of mitosis (the DNA synthesis 
phase) to replicate (Maclachlan & Dubovi, 2016; Cotmore & Tattersall, 2014; 
Quinn et al., 2011; Oleksiewicz & Alexandersen, 1997). Consequently, tissues 
with dividing cells will be susceptible to parvovirus-induced cell damage and 
this influences the outcome of AD infections (Maclachlan & Dubovi, 2016).  
When adult mink are infected (classical AD), cells of the immune system will 
be the primary locations for replication (B cells, macrophages, and dendritic 
cells) (Kanno et al., 1993; Aasted & Leslie, 1991; Mori et al., 1991; 
Alexandersen et al., 1988; Porter, 1986; Porter et al., 1980). The virus crosses 
the placental barrier in mink infected both prior to and during pregnancy 
irrespective of the female mink has previous ADV antibodies or not (Broll & 
Alexandersen, 1996; Clewley et al., 1987; Mengeling, 1978; Mengeling & 
Cutlip, 1976). Infections during gestation will therefore affect the foetuses since 
they have a large amount of actively dividing cells. Subsequently, there will be 
an increased risk for abortions, embryonic death, stillbirth and birth of weak kits 
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(Hansen & Lund, 1988; Padgett et al., 1967a). The decreased reproductive 
performance is often one of the most apparent clinical symptoms at herd level 
both in terms of an increased percentage of barren females as well decreased 
mean litter size (Broll & Alexandersen, 1996).  
In neonatal mink which have not been transplacentally infected or are born 
without maternal antibodies to ADV, the type II cells of the lungs will be the 
primary target cells leading to interstitial pneumonia, surfactant deficiency and 
an acute form of disease with high mortality (neonatal AD) (Alexandersen, 
1986). In contrast, AD has a chronical progression in neonatal mink with 
maternal antibodies since the maternal antibodies partially restrict the viral 
replication and limit tissue damage. The disease thereby resembles classical AD 
in adult mink (Alexandersen et al., 1989; Alexandersen, 1986).  
Apart from the direct cytopathic effects of ADV infection, most of the 
clinical signs of classical AD are diffuse and relate to the immune complex 
mediated organ damage: lethargy, anorexia, cachexia, polyuria, polydipsia, 
dehydration, uraemia, neurological symptoms, anaemia, thrombocytopenia, 
melena, and eventually death (Porter et al., 1980; Henson et al., 1976; Eklund et 
al., 1968).  
The degree of pathological lesions/clinical symptoms/mortality due to ADV 
infection is the net result of a combination of virus factors (strain and dose), host 
factors (genotype and age) and individual factors (immune status of the mink). 
In addition, the environment and different physiological determinants may have 
an effect (Gorham et al., 1976; Eklund et al., 1968): 
 
➢ Virus factors: There are hundreds of different strains of ADV described 
(Knuuttila, 2015; Christensen et al., 2011; Knuuttila et al., 2009b; 
Olofsson et al., 1999) which range from being highly virulent to avirulent 
(Knuuttila, 2015; Knuuttila et al., 2009b; Alexandersen et al., 1994; 
Aasted et al., 1984a). Example of highly pathogenic strains are ADV-
Utah 1, ADV-Ontario and ADV-TR (Oie et al., 1996; Hadlow et al., 
1983; Porter et al., 1969) while strains such as ADV-Montana and ADV-
Pullman are known to be moderately – low virulent strains (Hadlow et al., 
1983; Bloom et al., 1975). Alternatively, it has been argued that it is rather 
a difference in time for onset of pathological lesions where some strains 
cause higher levels of hypergammaglobulinemia and severe pathological 
lesions faster than other strains (Alexandersen et al., 1994; Johnson et al., 
1975; Porter et al., 1973; Padgett et al., 1967b). 
➢ Genotype of the mink: Mink with the Aleutian gene (Aleutian mink and 
colours crossbred with these) are more susceptible to infections, since the 
blue-grey pigmentation of the fur is linked to a lysosomal disorder causing 
immune deficiency and bleeding anomalies (the Chediak-Higashi 
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syndrome) (Anistoroaei et al., 2013; Hadlow et al., 1983; Bell et al., 1980; 
Bloom et al., 1975; Larsen & Porter, 1975; Padgett et al., 1967b). 
However, there is an interaction between the virus strain and the genotype 
of the mink. With the highly pathogenic strains, the genotype of the mink 
seems subordinate and mink of any colour type develop disease. In 
contrast, with a few exceptions, only mink with the Aleutian gene will 
develop severe disease when infected with low pathogenic strains of ADV 
(Hadlow et al., 1984; Hadlow et al., 1983; Porter et al., 1969; Eklund et 
al., 1968). Thus, it can be concluded that different strains of ADV differ 
in their ability to cause disease in Aleutian and non-Aleutian mink 
genotypes. Aleutian mink have been reported to typically die within a 
couple of months post-infection (Eklund et al., 1968) whilst non-Aleutian 
mink rarely die earlier than five months after infection and may survive 
for several years depending on virus strain (Hadlow et al., 1983; Porter et 
al., 1980; Gorham et al., 1965). 
➢ Individual factors: In general, disease develops faster in Aleutian mink 
than in non-Aleutian mink, but also among non-Aleutian mink the 
severity and rate of clinical signs vary greatly between individual mink 
(Eklund et al., 1968).  
 
Two principally different forms of ADV infection in adult mink have been 
reported:  
 
➢ Progressive persistent AD (classical AD): With time after infection with 
ADV, the levels of IgG continue to increase and the clinical disease 
progresses (Porter et al., 1984a).  
➢ Non-progressive AD (NP-AD): This form of AD can further be 
differentiated into (i) persistent NP-AD characterized by low antibody 
titres, low levels or absence of hypergammaglobulinemia, no pathological 
lesions but ADV in limited amount in internal organs (Bloom et al., 1994; 
An & Ingram, 1977), and (ii) transient NP-AD where the mink have a 
normal cellular immune response (An & Wilkie, 1981), low and 
decreasing antibody titres, transient increase of serum gamma globulin 
and no viremia (Jackson et al., 1996; Porter, 1986; Hadlow et al., 1984; 
An & Ingram, 1977; Henson et al., 1976; Larsen & Porter, 1975; Eklund 
et al., 1968). It has been estimated that the non-progressive form of AD 
may correspond to 25-40% of the infections in non-Aleutian mink (An et 
al., 1978; Larsen & Porter, 1975).  
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1.5 Detection of ADV and diagnosis of AD and 
hypergammaglobulinemia 
In general, diagnostic tests for viral infections can be based on identification of 
cytopathic cellular changes, virus isolation, detection of viral components or 
evaluation of the immune response to the infection (Murray et al., 2015). While 
histopathology is a good method for diagnosing AD in euthanized mink, 
methods that can be performed on live mink are preferable when screening for 
AD in a mink herd. Since field strains of ADV are challenging to grow in cell 
culture (Bloom et al., 1980), two important diagnostic methodologies for ADV 
infection and AD are identification of viral components and evaluation of the 
immune response.  
1.5.1 Identification of viral components  
Identification of ADV components can be performed with polymerase chain 
reaction (PCR) or real-time PCR (Prieto et al., 2014; Jensen et al., 2011). PCR 
has three main advantages: (i) it detects presence of virus DNA, (ii) it is an 
extremely sensitive technique, and (iii) with real-time PCR it can also be used to 
estimate the viral load in the sample (Maclachlan & Dubovi, 2011). However, 
there are also some drawbacks: (i) the method is so sensitive so that 
contamination during sampling in a farm environment can easily occur and lead 
to a false positive result (Maclachlan & Dubovi, 2011), (ii) since viremia and 
faecal excretion is intermittent, samples from spleen and/or mediastinal lymph 
nodes are preferred and this means in reality that the mink need to be euthanized 
(Jensen et al., 2014; Jensen et al., 2011; Maclachlan & Dubovi, 2011), and (iii) 
PCR for ADV is substantially more expensive than other available diagnostic 
methods (SVA, 2016) and therefore not suitable for mass screening purposes. 
Consequently, PCR is best used for confirmation of dubious results or for virus 
sequencing (Jensen et al., 2011).  
1.5.2 Detection of the immune response  
The immune response following ADV infection is a key factor in the 
development of disease and can be mirrored by detection of ADV specific 
antibodies (the ADV infection) or by detection of increased level of serum 
gamma globulins (the hypergammaglobulinemia). 
For detection of specific ADV antibodies, several different serological 
methods have been developed (Farid & Segervall, 2014; Knuuttila et al., 2009a; 
Aasted et al., 1986; Alexandersen & Hau, 1985; Aasted & Cohn, 1982; Crawford 
et al., 1977) based on the fact that in ADV, antibodies are directed at both the 
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structural (VP2 and VP1) and the non-structural proteins (primarily NS1) 
(McKenna et al., 1999; Bloom et al., 1997; Porter et al., 1984a; Porter et al., 
1984b; Bloom et al., 1982). In counter immunoelectrophoresis (CIEP), an 
electrophoresis is performed with the ADV antigen on one side and plasma 
samples from the mink on the opposite side of an agarose gel (Cho & Ingram, 
1972). When the electrical voltage is applied, the negatively charged antigen will 
move towards the anode (Figure 6a). If the plasma sample contains ADV 
antibodies, which are positively-charged, they will move towards the cathode 
and meet the antigen on its way. As a result, antigen-antibody immune 
complexes will form and can be visualized as a white precipitation line on the 
agarose gel (Figure 6b; (Cho & Ingram, 1972)). When CIEP was first introduced 
in the early 1970’s by Cho and Ingram(Cho & Ingram, 1972), the antigen used 
was whole virus propagated in mink. During the early 1980’s, cell culture 
derived virus antigen was introduced (Aasted & Cohn, 1982). Since then, one of 
the most widely strains for diagnostic purposes has been the ADV-G strain 
which is a non-pathogenic strain derived from an initially highly pathogenic 
strain (Utah 1) (Bloom et al., 1980). Even though CIEP has not been completely 
validated according to the standards presented by OIE, it has been used for 
diagnosing ADV infections in mink in many countries and has since long been 
regarded as the gold standard test for ADV infection (Knuuttila, 2015; Bloom et 
al., 1997; Uttenthal, 1992; Cho & Greenfield, 1978). The sensitivity has been 
estimated to 79% - 99% and the specificity to 90% - 100% (Dam-Tuxen et al., 
2014; Knuuttila et al., 2014; Aasted et al., 1986; Wright & Wilkie, 1982).  
 
 
Figure 6. Counter immunoelectrophoresis – (a) the set-up (to the left), and (b) the white 
precipitation line formed when antigen and ADV antibodies meet (to the right). Photo by SVA. 
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Figure 7. Performance of an ELISA. Photo by SVA. 
Several different enzyme-linked immunosorbent assays (ELISA systems; 
Figure 7) have also been developed and evaluated for diagnosis of ADV 
infection (Dam-Tuxen et al., 2014; Knuuttila et al., 2014; Knuuttila et al., 2009a; 
Wright & Wilkie, 1982). The first ELISA for detection of ADV antibodies was 
based on whole virus antigen (Guelph strain) (Wright & Wilkie, 1982). 
However, due to false negative results in comparison to CIEP, ELISA was for 
many years considered not suitable for diagnosis of ADV infection. In 2009, a 
new ELISA system for ADV based on recombinant VP2 antigen was presented 
that detected ADV infected mink with high sensitivity and specificity when 
compared with CIEP (Knuuttila et al., 2009a). In parallel, an ELISA system 
based on whole virus antigen (ADV-G) was manufactured and used in North 
America (Aleutian Disease Virus (AMDV) Antibody ELISA Test, Reference 
ADV3005, Scintilla Development Company LLC, Bath, Pennsylvania, USA). 
However, until this project started, no scientific validation of the latter had been 
published. As the ELISA systems became a more reliable diagnostic tool for 
ADV infection in mink, the possibility to develop an automated ELISA was 
considered. In 2014, an automated ELISA based on a modified form of the 
ADV-G antigen, traditionally used in CIEP, was developed and scientifically 
evaluated (Dam-Tuxen et al., 2014). The same year, an adaptation of the ELISA 
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based on the recombinant VP2 antigen for an automated system was also 
published (Knuuttila et al., 2014). The largest advantage of the ELISA compared 
to CIEP is that it can be used both for qualitative and quantitative detection 
without any dilution steps. Also, the ELISA is an objective assay which is not 
dependent upon any subjective interpretation of the visual appearance of the 
agarose gel as CIEP is.  
Both the available ELISA systems and CIEP are dependent upon production 
of IgG antibodies in the mink, and therefore a positive test result cannot be 
expected until a couple of weeks after infection (Farid et al., 2015; Jensen et al., 
2014; Hadlow et al., 1985; Hadlow et al., 1983). However, the advantage of 
serological methods are that they detect the immunological response to the 
infection rather than presence of the infectious agent per se (Maclachlan & 
Dubovi, 2011) even though a possible limitation is the risk of misclassifications 
i.e. false positive and false negative results (Murray et al., 2015). Several studies 
have compared the diagnostic performance of CIEP with other methods such as 
ELISA, and the position of CIEP as gold standard has been questioned (Dam-
Tuxen et al., 2014; Farid & Segervall, 2014; Knuuttila et al., 2014; Knuuttila et 
al., 2009a; Wright & Wilkie, 1982). For instance, it has been reported that CIEP 
underestimates the antibody titre and therefore might fail to identify ADV 
infected mink at an early stage of infection or mink with non-progressive AD 
i.e. when the antibody levels are low (Farid et al., 2015; Hadlow et al., 1985; 
Crawford et al., 1977; Bloom et al., 1975). 
In addition to detection of specific ADV antibodies, the characteristic 
hypergammaglobulinemia associated with AD can also be used as a diagnostic 
criterion. The serum of mink with progressed AD is characterized by an 
increased total amount of proteins, an increased proportion of gamma globulins 
and a decreased proportion of albumin (Cepica et al., 2012; An & Ingram, 1977; 
Porter et al., 1965b; Porter et al., 1965a; Henson et al., 1961). While the 
proportion of gamma globulins in serum/plasma of healthy mink is around 13% 
(An & Ingram, 1977; Porter & Dixon, 1966), a proportion of gamma globulins 
above 21% has been suggested to represent AD associated 
hypergammaglobulinemia (Cepica et al., 2012; An & Ingram, 1977; Porter et 
al., 1965b; Porter et al., 1965a; Henson et al., 1961). Alternatively, 
hypergammaglobulinemia can be expressed in terms of the ratio between 
albumin and gamma globulin (the A:γG ratio). It has been reported that a ratio 
greater than 8 represents healthy mink while a ratio lower than 5 represents mink 
with hypergammaglobulinemia (Cepica et al., 2012). 
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Figure 8. Serum protein profiles in mink with (to the left) and without (to the right) 
hypergammaglobulinemia.  
For the purpose of detecting hypergammaglobulinemia in mink, one 
alternative is the iodine agglutination test (IAT) (Mallen et al., 1950). In IAT, 
the test solution reacts with gamma globulins in the serum leading to a 
precipitation in mink with hypergammaglobulinemia (Porter et al., 1980; 
Greenfield et al., 1973; Mallen et al., 1950). The IAT is a simple and non-
expensive test which has been used at farms since the 1960s when it was first 
introduced (Greenfield et al., 1973; Mallen et al., 1950). IAT is not a specific 
test for AD since the test identifies an increased amount of gamma globulins 
which is a feature typical but not exclusive for AD (Cepica et al., 2012). In areas 
with endemic AD, however, the power of the test will be sufficient due to the 
high prevalence of AD compared to other diseases which could cause a 
corresponding hypergammaglobulinemia (Cepica et al., 2012). Another 
limitation of IAT is that it is a qualitative test that identifies mink with marked 
hypergammaglobulinemia i.e. relatively late in the disease process (Cepica et 
al., 2012; Gorham et al., 1964). Expressed in terms of A:γG ratio, the IAT 
identifies a A:γG ratio of less than 1 as diseased (Gorham et al., 1965). 
Consequently, ADV infected mink with an A:γG ratio greater than 1 will remain 
undetected (Cepica et al., 2012; Cho & Ingram, 1972).  
There are other alternative ways of identifying an increased amount of serum 
gamma globulin which offer better possibilities to quantify the degree of 
hypergammaglobulinemia and thereby also indicate the degree of AD 
progression (Bloom et al., 1994). Examples include serum electrophoresis 
(Porter et al., 1980) and MALDI-ToF (Cepica et al., 2012). However, these 
methods are either expensive, laborious, or technically demanding and therefore 
not easily used for mass screening purposes. Consequently, there is a need for a 
simpler method to separate animals based on their degree of disease progression 
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and quantitative ELISA systems have been suggested to fit such a purpose. 
However, before a new diagnostic test can be implemented it needs to be 
sufficiently evaluated and validated (OIE, 2013). 
1.6 Evaluation of diagnostic tests  
There is no such thing as a perfect diagnostic test, and any test will as a 
consequence inevitably lead to misclassifications (Greiner & Gardner, 2000). 
Knowledge about the probability for misclassifications is therefore essential 
before applying the test in research or in a clinical setting. Before any evaluation 
of a new diagnostic assay the purpose of the test must be defined as this will 
have a large impact on the assessment of the test performance (OIE, 2014a). 
Demonstrating disease-free status require tests with high sensitivity resulting in 
low false negative rates and maximum negative predictive values for low-
prevalence populations (OIE, 2014a). For a similar reason, eradication of a 
disease also requires a test with high sensitivity, especially at the late stages of 
the elimination process when prevalence is low (OIE, 2014a). In both these 
cases, a confirmatory test with high specificity and low false positive rate can be 
applied in order to more accurately evaluate the disease status of the individual 
(OIE, 2014a). For disease prevalence estimates, a test with both moderate to high 
sensitivity and moderate to high specificity is optimal (OIE, 2014a). For tests 
based on a continuous scale rather than a binary outcome, the results are often 
categorized into two to three categories. If there is an overlap in distributions of 
test values between the different categories, the selected cut-off values must then 
be aimed to fit the selected purpose (OIE, 2013).  
1.6.1 Precision 
The precision of a diagnostic test can be described as the ability of the test to 
produce the same result at different assay occasions and compromises both the 
repeatability and the reproducibility (Greiner & Gardner, 2000): 
 
➢ Repeatability: This is an estimation of the internal consistency i.e. the 
variation at the laboratory(European Medical Agency, 1995) when things 
such as instruments, procedures, materials etc. are being held constant 
(United Nations Office on Drugs and Crime, 2009). Repeatability is often 
expressed as intra-assay variability. Factors affecting this variability 
could be poor washing efficiency, variations in the plate coating, un-stable 
antigens, pipetting errors and non-optimized incubation times (Shan, 
2010). 
32 
 
➢ Reproducibility: This is an estimation of both the within laboratory 
variations as well as the external consistency i.e. the variation between 
different laboratories (United Nations Office on Drugs and Crime, 2009; 
European Medical Agency, 1995). Reproducibility can be expressed as 
the inter-assay variability compromising for instance intra-observer 
variation, inter-observer variation and factors such as the day of the 
analysis (United Nations Office on Drugs and Crime, 2009; 
Kanchanaraksa, 2008). 
 
Precision is commonly measured as the coefficient of variation (CV) which 
is the standard deviation (SD) of the repeated measurements divided by the mean 
of the measurements (Dohoo et al., 2009). Estimations of the CV are 
concentration-dependent and should therefore always be evaluated at different 
concentrations throughout the working range of the diagnostic tool (United 
Nations Office on Drugs and Crime, 2009). As a guideline, less than 15% intra-
assay variation and less than 20% inter-assay in the CV have been regarded as 
acceptable (Shan, 2010; United Nations Office on Drugs and Crime, 2009; OIE, 
2008). 
1.6.2 Accuracy 
The accuracy is a measurement of the ability of the test to reflect reality i.e. the 
test performance (Greiner & Gardner, 2000). In diagnostic assay evaluations, it 
is often measured in terms of sensitivity and specificity in relation to another test 
such as a gold standard (Figure 9; (Greiner & Gardner, 2000)). Sensitivity is 
defined as the proportion (a/(a+c)) of diseased individuals (a+c) who are 
identified by the diagnostic test as diseased/ true positives (a) and not as false 
negatives (c). Specificity is defined as the proportion (d/(b+d)) of non-diseased 
individuals (b+d) who are identified as non-diseased/ true negatives (d) and not 
as false positives (b)(Dohoo et al., 2009). 
 
 
 
 Disease positive Disease negative 
Test positive a b 
Test negative c d 
 
Figure 9. Two-by-two table of the test result vs the disease status of the animal as decided with the 
reference test. Sensitivity is calculated as a/(a+c) and specificity is calculated as d/(b+d). 
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There are several factors that may affect the evaluation of the test 
performance and therefore estimations of test performance should be regarded 
to be valid only for the given reference population under the defined conditions 
(Gardner et al., 2000). The influencing factors can be divided into biological 
factors and test related factors e.g. choice of reference test and selected cut-off 
(OIE, 2008). 
Biological factors 
Sensitivity and specificity of a test can vary both within and among animal 
populations and sub-populations (Greiner & Gardner, 2000). Disease 
prevalence, composition of the population (e.g. age, gender, colour type, 
gestation) as well as the sample size may influence the test performance (OIE, 
2008). Hence, it is crucial to evaluate the diagnostic test in the population where 
it is going to be used. Also, the sample used during the evaluation must be 
representative for the overall population. If the population later changes in e.g. 
terms of infection load it is recommendable that the accuracy of the test is re-
evaluated (OIE, 2008). 
In addition, there are biological factors within the individual animals which 
may influence the test performance (Greiner & Gardner, 2000). One example is 
intra-subject variability where short-term variations in the results of the same 
individual (e.g. as the result of physiological changes) will introduce error into 
estimations of the test performance (Kanchanaraksa, 2008). Other examples of 
biological factors at the individual level which may affect the estimations of 
sensitivity and specificity are the stage of infection, the immune status, and other 
coexistent diseases (Greiner & Gardner, 2000).  
The reference test (the gold standard) 
Ideally, the gold standard should be a perfect reference standard in order to be 
representative of the true disease status of the animal population (OIE, 2013; 
Thrusfield, 2007). However, apart from direct isolation of the organism or 
pathognomonic histopathological criteria, other tests for disease status risk to 
suffer from errors (OIE, 2014b; OIE, 2008). When using such tests as reference 
tests, there is a risk for misclassifications and the estimated sensitivity and 
specificity of the new assay risk to be flawed (OIE, 2014b; OIE, 2014a). One 
way to improve the gold standard classification is to use multiple testing (Dohoo 
et al., 2009), either by re-testing the test positives/ test negatives from the first 
test (sequential multiple testing) or testing all individuals with both tests 
(simultaneous multiple testing). Another way to improve the assessment of 
disease status is to use a population with known disease status (Thrusfield, 
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2007). For ADV, this can be translated into using ADV seronegative herds to 
find ADV seronegative animals, and inoculating these ADV seronegative mink 
with ADV with the aim of achieving ADV seropositive animals. A third 
alternative to handle imperfectness of the reference test is to statistically adjust 
the estimated sensitivity and specificity for the new test using Bayesian or 
Maximum likelihood latent class analysis (LCA) (OIE, 2014c; Georgiadis et al., 
2003; Staquet et al., 1981; Hui & Walter, 1980). 
If possible, the gold standard should be conditionally independent from the 
test validated, i.e. measuring a different biological process (Georgiadis et al., 
2003; Gardner et al., 2000). Two tests measuring similar analytes such as 
antibodies, however, are likely to be conditionally dependent given the animal’s 
true disease status (Georgiadis et al., 2003; Gardner et al., 2000). This introduces 
another source of error when estimating the sensitivity and specificity of the new 
test in which a new test which is more similar to the gold standard will appear 
superior compared to a test which is less similar irrespective of true superiority. 
Any correlation between the tests needs to be addressed during the statistical 
analysis or otherwise the estimations can be biased (Dohoo et al., 2009; 
Georgiadis et al., 2003; Gardner et al., 2000).  
Selection of cut-off value 
For tests that measure on a continuous scale, such as ELISA, a cut-off needs to 
be created in order to enable categorization of individuals as diseased or non-
diseased. Different cut-off points will lead to different estimations for sensitivity 
and specificity, and the evaluation of one test compared to another test will 
dependent upon the cut-off values chosen (Dohoo et al., 2009). For instance, a 
cut-off that identifies more true negatives (high specificity) will also lead to more 
false negative results. In contrast, a cut-off that identifies more true positives 
(high sensitivity) will lead to more false positive results (Giesecke, 2001). 
Sensitivity and specificity are inversely related to each other so that when one 
of them increases, the other one will decrease (Figure 10). The choice of cut-off 
is therefore a balance act depending on the purpose of the diagnostic test. 
(Giesecke, 2001). 
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Figure 10. Example of distributions of antibody levels for non-infected animals (left) and infected 
animals (right) tested with a test measuring on a continuous scale. The overlap between the test 
values (grey area) include animals which are at the risk of misclassification depending on the 
selected cut-off. A low cut-off will classify all infected animals as test positive as well as some of 
the non-infected (grey area) i.e. high sensitivity but lower specificity. A high cut-off will classify 
all non-infected animals as test negative as well as some of the infected (grey area) i.e. high 
specificity but lower sensitivity. 
One commonly used way to decide the cut-off is to take the mean result of a 
healthy population/sub-population and add two or three standard deviations 
(Jacobson, 1998). Statistically, this ensures a specificity of 97.5 – 99.5% i.e. 97.5 
– 99.5% of the healthy population will be test negative and the remainder will 
be test positive. An alternative method to determine the cut-off is using a 
receiver-operating characteristic (ROC) analysis (Zweig & Campbell, 1993; 
Hilden, 1991). This is a graphical tool where the area under the curve (AUC) 
represents the probability that a randomly chosen diseased individual has a 
greater test value compared to a randomly selected healthy individual (Fawcett, 
2006). Through maximization of AUC, the optimal cut-off can be estimated. It 
is possible to optimize both sensitivity and specificity or only one of them. 
Depending on the test in question, this can lead to different estimations for the 
cut-off value (Fawcett, 2006; Zweig & Campbell, 1993; Hilden, 1991). 
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The overall aim of this thesis was to obtain knowledge about serodiagnosis of 
ADV infection and Aleutian disease in Swedish mink, and to develop strategies 
to reduce the impact on welfare and reproduction in mink in ADV endemic areas 
using estimation of ADV antibodies as a tool. The specific objectives were: 
 
➢ To evaluate two different available ELISA systems for serological diagnosis 
of ADV infection and select the most suitable system for serodiagnosis in 
Swedish mink (I). 
➢ To adapt and validate the serum VP2 ELISA selected in I for ADV antibody 
detection in dried blood spots (DBS) with the aim to facilitate sampling and 
preparations of samples for analysis (II) 
➢ To evaluate the short-term stability of the estimated antibody levels of mink 
(III). 
➢ To investigate the relationship between ADV antibody levels, estimated with 
the DBS VP2 ELISA, and amount of gamma globulins in serum of mink (II). 
➢ To evaluate long term consistency of the estimated antibody level and disease 
status of mink (III).  
➢ To evaluate the association between the AD status of female mink, estimated 
with the DBS VP2 ELISA, and their reproductive performance, expressed as 
being barren or not and litter size per non-barren female mink (IV). 
  
2 Aims and objectives of the thesis 
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A brief description of materials and methods used in this thesis are presented 
below. More detailed information is given in papers I-IV. In addition, details on 
extra data analyses performed in the thesis are given in the section Addendum.  
3.1 Study populations and study designs 
All herds studied in I – IV were affiliated to the Swedish national health program 
for mink and situated in the southern part of Sweden where most Swedish mink 
herds were situated. Participation in all studies was voluntary. 
I was designed as an observational cross-sectional study. All ADV positive 
herds in Sweden (n=58) were offered the opportunity to join and a convenient 
sample of voluntary farmers, stratified over the three different mink-producing 
areas was made (n=4). Blood samples from a random sample of 50-100 female 
mink older than 6 months of age were collected from each herd during December 
2010. Negative control samples were collected from 25 randomly selected 
female mink originating from an ADV seronegative herd which was, at the time, 
the only herd in Sweden which had been sampled for ADV yearly and had not 
had any ADV positive test samples over the last ten years.  
II was also designed as an observational cross-sectional study including mink 
from two ADV positive herds. The herds were selected as a convenient sample 
based on the criteria that they both had a high prevalence of seropositive animals 
during previous screening but differed in herd size as well as reproductive 
performance. Moreover, to enable sampling within the stipulated time frame, a 
relative proximity of the herds but not directly adjacent to each other 
(approximately 10 km apart) was a decisive criterion. A random sample of 90 
female mink from three different non-Aleutian colour types (brown, silver blue 
and Hedlund white) were sampled from each herd. In addition, data from routine 
screening of 300 silver blue mink from a low-prevalence ADV positive herd as 
3 Materials and methods 
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well as 1,008 mink (brown, silver blue and Hedlund white as well as sapphire 
colour type) from an ADV seronegative herd sampled within the framework of 
the Swedish national health program for mink were included.  
III was a descriptive case-serial study divided into two parts. For the 
investigation of the short-term stability, 120 of the 180 mink scrutinized in II 
were further sampled and included as the study population in III part I. For the 
long-term consistency, data from a high-prevalence ADV positive herd with data 
from two consecutive routine screenings of 350 Hedlund white mink in October 
2011 and February 2012 were used as study population in III part II.  
IV was a retrospective observational cohort study. Data from routine ADV 
antibody analysis of DBS samples as well as registered reproductive 
performance data from four ADV infected herds collected within the framework 
of the Swedish national health program for mink in 2012 and 2013 (Svensk 
Mink, 2017) were used in the study. First, a pilot study was performed (IV pilot) 
including 1,001 primiparous and 1,075 older female mink of three different non-
Aleutian colour types (brown, silver blue and Hedlund white) from one herd 
bred with the same colour and with a complete record of the reproductive 
performance. In order to confirm the findings in IV pilot, a follow-up study (IV 
follow-up) was performed and a total of 10,638 female mink from of the same three 
non-Aleutian colour types from four different mink herds were scrutinized.  
3.2 Collection of samples for serological analysis 
3.2.1 Serum/plasma samples 
Serum and plasma samples were collected into glass capillary tubes from toe-
nail. Tubes with Natrium-heparin were used for plasma, and tubes without 
additive were used for serum. The capillary tubes were directly transported to 
the lab, centrifuged at 850 gs and stored in -20°C until analysis. After thawing, 
plasma and serum, respectively, were harvested through breakage of the tubes at 
the interface between the cell fraction and the plasma/serum fraction.  
3.2.2 DBS samples 
In II, III and IV, capillary blood samples from individual mink were or had 
been collected as DBS by toe nail clips onto filter papers. To avoid cross-
contamination of samples, each filter paper was air-dried and stored individually 
until analysis. The analysis was initiated by manually punching out 25 mm2 of 
each DBS, which corresponded to approximately 5 µL of serum (Aulerich et al., 
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1999). Each punch of filter paper was placed in a separate well of a flat bottomed 
96-well plate containing 200 µL elution buffer over night in order to elute the 
dried blood. The next day, the eluates were transferred to another microtiter 
plate. 
3.3 Laboratory diagnostics 
3.3.1 CIEP 
CIEP was used as the reference gold standard test in I and II. In I, CIEP was 
performed according to a modified protocol previously described (Cho & 
Ingram, 1972). Glass slides were coated with 0.8% agarose in barbital buffer. 
Undiluted plasma samples were placed in anodal wells. In the cathodal wells, a 
commercial CIEP antigen was applied. Positive controls were included on each 
slide. Following electrophoresis, the plates were viewed under indirect 
illumination and evaluated by two observers. Weak positive reactions were re-
evaluated after the gel had been soaked for 60 min in 0.9% saline and dried. Only 
samples with an immunoprecipitation line remaining after soaking were 
recorded as positive. In II, data from routine CIEP analysis of plasma samples 
performed at Kopenhagen Diagnostics, Glostrup, Denmark were used.  
3.3.2 Plasma ADV-G ELISA 
Blood plasma samples were analysed with the ADV-G ELISA kit in I according 
to the instructions of the manufacturer. Plasma samples were diluted 1:100 in 
phosphate-buffered saline (PBS) and added to the microtiter plates. Positive and 
negative controls were included on each plate. All incubations were 30 minutes 
and protein A-HRP was used as conjugate. The optical density was measured at 
450 nm (OD450) and the mean OD450 value of the blank wells was subtracted 
from each result. In order to evaluate if the mink were seropositive to ADV, two 
different cut-offs were calculated and used (i) the mean OD450 value + 10 SD of 
the negative control samples (as suggested by the manufacturer), and (ii) the 
mean OD450 value + 3 SD of the CIEP negative samples (Jacobson, 1998) in 
order to be comparable to the cut-off used for the serum VP2 ELISA (see below). 
3.3.3 Serum VP2 ELISA 
In I, II and III, a VP2 ELISA was used to analyse antibodies in mink serum 
according to a previously published protocol (Knuuttila et al., 2009a). Microtiter 
plates were coated overnight with antigen diluted in coating buffer and then 
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blocked with blocking buffer. Serum samples were diluted 1:200 in dilution 
buffer and added to the wells of the microtiter plates. All incubations were 60 
minutes and peroxidase-conjugated goat anti-cat IgG was employed as reagent 
solution. The optical density was measured at 450 nm (OD450) and the mean 
OD450 value of the blank wells was subtracted from each result. Positive and 
negative controls were included on each plate, and in II and III the OD450 values 
of each plate were adjusted to a value of OD450 = 1.0 for the positive control. 
The assay cut-off value was calculated as the mean OD450 value + 3 SD of the 
CIEP negative samples according to the published protocol (Knuuttila et al., 
2009a). 
3.3.4 Serum electrophoresis 
In II, capillary serum samples were collected and sent to the Department of 
Clinical Sciences at the Swedish University of Agricultural Sciences, Uppsala 
where the proportions of the different serum proteins were determined by serum 
electrophoresis. The degree of hypergammaglobulinemia for each mink was 
then estimated as the ratio between the amount of albumin and gamma globulins 
(the A:γG ratio) (Cepica et al., 2012). 
3.3.5 DBS VP2 ELISA 
In II, III and IV, antibodies to ADV in DBS were estimated by adapting the 
VP2 ELISA previously used for serum. When serum and DBS were compared, 
the analysis protocols were the same except for the dilutions of serum and DBS 
samples. The optimal dilution of the DBS was found by stepwise dilution of the 
samples from the ADV seronegative herd in II. The DBS eluate dilution when 
all samples had an OD450 value of less than the mean OD450 value + 2 SD of the 
original dilution (1:5) was decided to be optimal i.e. an eluate dilution of 1:20 
corresponding to a serum dilution of 1:800. Through ROC analysis, the assay 
cut-off values for ADV infection and different levels of AD progression based 
on the classifications by Cepica et al. 2012, were defined (Figure 11).  
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Figure 11. The definition of ADV infection and different levels of AD progression based on the 
classifications by Cepica et al., 2012. 
3.4 Registration of reproductive performance 
In farms associated to the Swedish national health program for mink (Svensk 
Mink, 2016), the staff count the number of kits during the first eight weeks and 
both the percentage of barren females and the number of kits born per female 
mink are annually reported to the program by the farmer. Data on the 
reproductive performance used in IV were obtained from a control program for 
AD within the framework of the health program (Svensk Mink, 2017; Svensk 
Mink, 2016). For the herds scrutinized in IV pilot and IV follow-up, the number of 
kits had been counted by the farm personnel when the kits were two to four 
weeks of age during May 2012 and 2013, respectively (Svensk Mink, 2017).  
3.5 Statistical analyses  
Statistical analysis was used in all four papers to investigate test performance, 
evaluate significant differences between different test groups or to assess the 
association between various factors. All statistical analyses and graphical 
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presentations were made in Stata (Stata/IC 13.1, StataCorp LP, College Station, 
Texas 77845, USA). A p-value of less than 0.05 was considered to be statistically 
significant. 
3.5.1 Evaluation of the different serum/plasma ELISA systems 
In I, the antibody levels (estimated as OD450 values) for CIEP negative and CIEP 
positive mink were compared using a t-test. Sensitivities and specificities for the 
different ELISA systems were calculated with the CIEP as reference gold 
standard test. The cut-off used was calculated either by the mean OD450 value + 
3 SD of the CIEP negative samples (Jacobson, 1998) , or for the ADV-G 
antibody ELISA, the mean OD450 value + 10 SD of the negative control samples 
provided in the kit (according to the instructions from the manufacturer). 
3.5.2 Evaluation of the DBS ELISA 
In II, the precision of the DBS VP2 ELISA was evaluated through intra-assay 
as well as inter-assay variability: 
 
➢ The intra-assay variability was estimated for 11 randomly selected DBS 
samples tested in six replicates in a single assay. This was repeated during 
two consecutive days and the CV for each sample each day was calculated 
by dividing the SD of the six replicates for each sample with the mean 
OD450 value for all the replicates. The overall intra-assay variability was 
then computed as the mean CV for all samples. 
➢ The inter-assay variability was evaluated by comparing the mean OD450 
value for two duplicate wells for each DBS sample analysed during three 
consecutive days. The CV was calculated as for the intra-assay variability, 
both for the individual DBS samples as well as the overall inter-assay 
variability. 
 
The accuracy of the DBS VP2 ELISA to categorize mink from the low-
prevalence herd as seropositive or seronegative was first evaluated with CIEP as 
the reference gold standard test. The mean DBS antibody levels (again estimated 
as OD450 values) for CIEP positive and CIEP negative mink were then compared 
using a paired t-test assuming unequal variance. The sensitivity and specificity 
for the DBS ELISA compared to CIEP were calculated using the assay cut-off 
defined by ROC analysis earlier in II.  
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3.5.3 Evaluation of ELISA as a tool for determining AD progression 
A major focus of this project was to evaluate the capacity of the DBS VP2 
ELISA to quantitatively estimate the amount of ADV antibodies as an indirect 
measurement of disease progression. Therefore, in a first step, the correlation 
between the quantitatively estimated OD450 values for DBS and serum samples 
in II were compared by calculating the Spearman rank correlation for the paired 
samples from the same mink. Thereafter, the Spearman rank correlations 
between the A:γG ratio and the serum/DBS VP2 ELISA OD450 values were 
calculated and the linear associations between serum/DBS VP2 ELISA OD450 
values and A:γG ratio were investigated using linear regression models. Prior to 
the analysis, OD450 values for DBS were transformed using the natural logarithm 
(ln). By stratifying the A:γG ratio into three categories representing diseased, 
ambiguous and healthy mink respectively (Figure 11), the mean OD450 values 
for DBS and serum samples for each category were statistically assessed using 
a paired t-test assuming unequal variances. The sensitivity and specificity for the 
DBS ELISA to predict diseased mink using the assay cut-off defined in by ROC 
analysis earlier in II. 
3.5.4 Evaluation of the stability of antibody levels estimated with the 
VP2 ELISA  
For the short-term stability in III part I, the OD450 values were normally 
distributed and statistical calculations comparing the consecutive sampling 
occasions were made with a two one-sided test for equivalence (TOST) testing 
the null hypothesis that there was a difference between the consecutive 
samplings (Shtaynberger & Bar, 2013; Schuirmann, 1987). The margin of 
equivalence was set to a level compensating for the methodological variability 
reported in II, ensuring that any difference in antibody levels would be the result 
of a true difference and not the methodological variance. In other words, 
equivalence between the two samplings was decided when the 95% confidence 
interval (CI) for the observed difference between the two measurements was 
within ±0.1 OD450 units (Shtaynberger & Bar, 2013).  
As the distribution of the OD450 values used for the evaluation of the long-
term consistency in III part II was bimodal the statistical comparison of the two 
sampling occasions were made with a non-parametric paired-samples sign test 
testing the null hypothesis that there was no difference between the two 
samplings. In addition, the Spearman rank correlation between the two sampling 
occasions was calculated. In order to evaluate whether the infection and disease 
status of the individual mink were preserved from the first to the second 
sampling, the data were tabulated and visually assessed.  
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3.5.5 Association between AD status and reproductive performance 
A multivariable zero-inflated Poisson (ZIP) regression model was used to 
investigate the associations between the reproductive performance and the 
explanatory variables AD status, colour type and age in IV pilot. The aim was to 
investigate the effects of the process that results in having kits or not (binary 
outcome) and the process that results in the actual size of the litter (count 
outcome). Moreover, to facilitate comparisons between the results from IV pilot 
with those from IV follow-up, we also built two separate models for the binary and 
the count outcome including only the primiparous female mink. A univariable 
mixed-effects logistic regression model was used to investigate the association 
between being barren or not (binary outcome) and AD status. A univariable 
mixed-effects Poisson regression model was then used to investigate the 
association between litter size and AD status. In the latter model, all barren 
females were excluded. In both models, colour was included as a random effect 
using an independent covariance structure.  
Initially, all potential explanatory variables were included and the final model 
was accomplished with a manual backward selection approach. A p-value ≥0.05 
was used to eliminate variables in a step-wise manner. In order to reveal any 
confounder, a limit was set for a maximum change in the coefficient of ±10%. 
All possible interactions between significant main effects were also investigated 
and included in the model when the interaction term was significant (p<0.05). 
Collinearity between the explanatory variables was assessed by pairwise 
Spearman rank correlations. A level of r ≥ 0.70 was used as a proof of 
collinearity and if present, the variable with lowest p-value was selected. Finally, 
the Vuong test was used to evaluate the ZIP model compared to an ordinary 
Poisson model.  
In IV follow-up, when data from primiparous mink in four different herds were 
included, the direct effect of colour type or herd was not of interest and a model 
which could include repeated measurements within herd and colour type as 
random effects was preferred over the zero-inflated model. Inclusion of repeated 
measurements within herd and colour type takes into account that mink within a 
herd and colour type are more similar than mink between different herds and 
colour types. Therefore, two separate models were applied for the binary and the 
count outcome. A univariable mixed-effects logistic regression model was used 
to investigate the association between being barren or not and the AD status of 
the female mink, and a univariable mixed-effects Poisson regression model was 
used to investigate the association between litter size and AD status. In the latter 
model, all barren females were excluded. For both models, an independent 
covariance structure was used allowing a distinct variance for each random 
effect. 
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3.5.6 Addendum 
In this thesis, the data in I were re-analysed using Bayesian LCA allowing CIEP 
and the two ELISA systems to be compared more equally. In a LCA, none of the 
tests is considered a gold standard. Instead, the sensitivity and specificity, as well 
as the prevalence of the investigated disease in each of the populations, are 
simultaneously estimated for all tests. Neither of the three tests used in I could 
be assumed completely conditionally independent on the AD status since they 
all measure antibodies. Hence, a model (1) allowing for conditional covariance 
between the two ELISA systems was first ran while assuming conditional 
independence of CIEP. In addition, models (2) allowing for conditional 
covariance between CIEP and each of the ELISA systems, or (3) assuming 
conditional independence between all tests, i.e. the Bayesian formulation of the 
LCA for three test in k-populations (Branscum et al., 2005), were also run. One 
of the advantages of Bayesian analysis is that all parameters can be modelled 
using distributions based on previous knowledge (so called priors). Informative 
priors for the sensitivity and specificity of the CIEP and the two ELISA systems 
were obtained from previously published studies (Dam-Tuxen et al., 2014; 
Knuuttila et al., 2014) while uniform priors were used for the prevalences and 
covariances. Based on these priors, alpha and beta parameters of the beta 
distributions were calculated using the probability calculator tool on the 
EpiTools website (Sergeant, 2016), and then used in the models. In addition, a 
model with uniform priors for all parameters were also run for comparison as 
the priors obtained were from only two studies. 
The LCA were performed using OpenBUGS, version 3. 2. 2 rev 1063 
(OpenBUGS, 2010–2011 Members of Open BUGS Project Management Group) 
which uses a Markov Chain Monte Carlo (MCMC) sampling algorithm (Gibbs 
sampling algorithm) to obtain a random sample from the joint posterior 
distribution of all model parameters. Three MCMC chains, with different 
starting values, were run for 20,000 iterations of the model, with a thinning of 1 
in 10, and the first 10,000 were discarded as the burn-in phase. Convergence of 
the MCMC chains after the initial burn-in was assessed by visual inspection of 
the time-series plots of selected variables as well as by inspecting Gelman-Rubin 
diagnostic plots and autocorrelation plots. The median of the posterior 
distribution was used as an estimate for the sensitivity and specificity of the three 
tests, the possible covariance of between the tests, and the prevalence in each 
population; the 2.5 and 97.5 points were used as estimates of the 95% posterior 
credibility intervals (PCI; the Bayesian analogue of CI). 
Complementary to the strategy for disease control developed in IV, the 
potential to use the quantitatively estimated antibody level as a tool to 
discriminate diseased mink with different levels of AD progression was also 
48 
 
investigated in this thesis. First, the litter size of each mated female mink was 
plotted against the OD450 value in February using the lowess command in Stata. 
To further investigate the association between the reproductive performance and 
the OD450 value of the female mink, two separate models for the percentage of 
barren females and the mean litter size of the non-barren female mink were then 
made. Unlike in IV, the mink were not categorized into diseased and non-
diseased but instead the OD450 value for each mink was initially used in the 
models.  
For the risk of being barren, a logistic regression model was made using the 
data from the 10,638 mink originally included in IV follow-up followed by 
estimation of the average predicted percentage of barren females for each OD450 
value using the margins command in Stata. In the next step, the female mink 
were subdivided into three categories based on the OD450 value: non-diseased 
(OD450 ≤ 0.8), diseased+ (OD450 0.9-1.1), and diseased++ (OD450 ≥ 1.2). A new 
logistic regression model was then made using these three categories and the 
average predicted percentage of barren females was estimated for each category. 
For the litter size of the non-barren female mink, a Poisson regression model 
was first made followed by estimation of the average predicted litter size per 
non-barren female mink for each OD450 value using the margins command in 
Stata. In a second step, a new Poisson regression model was made using the three 
new disease categories and the average litter size per non-barren female mink 
was then estimated for each disease category.  
3.6 Ethical consent 
The studies were approved by the Swedish Ethical Committee in Uppsala (Dnr 
C306/10) & the Swedish Ethical Committee in Gothenburg (Dnr 117-2012). 
Additional data were obtained from routine ADV antibody analyses of clinical 
screening samples. These samples were collected by the farmers and submitted 
for diagnosing ADV in their attempts to control the disease (i.e. not collected for 
scientific purpose). Further, the reproductive performance data were obtained 
within the framework of the Swedish national health program for mink in 2012 
and 2013, respectively (Svensk Mink, 2017).  
  
49 
 
4.1 Evaluation of different ELISA systems for detection of 
ADV antibodies 
4.1.1 Serum/plasma ELISA 
Several biological factors are known to affect the evaluation of the accuracy of 
a test and therefore the performance of a test should always be evaluated in the 
population where it is intended to be used (OIE, 2008; Gardner et al., 2000). In 
this thesis, the performance of two different available ELISA systems for 
detection of ADV antibodies were evaluated in Swedish mink (I).  
The mink were tested for ADV antibodies with CIEP, the ADV-G ELISA 
and the VP2 ELISA. The mean antibody level (defined as the OD450 value) for 
the groups of CIEP negative and the CIEP positive mink differed significantly 
(p<0.05) for both ELISA systems, respectively. Moreover, the accuracy for each 
ELISA system was expressed in terms of sensitivity and specificity using CIEP 
as the reference gold standard test (I) and also by LCA, in the extended data 
analysis in this thesis, allowing a more equal comparison between all three tests.  
For the ADV-G ELISA, the cut-off value for categorizing plasma samples as 
negative or positive was defined as OD450 = 0.19 when the cut-off value was 
calculated based on the negative control samples (as suggested by the 
manufacturer). The estimated sensitivity and specificity using this cut-off were 
54.3% and 93.2%, respectively. The second cut-off investigated was defined as 
OD450 = 0.28 (based on the mean OD450 value +3 SD of the CIEP negative 
samples). The estimated sensitivity and the specificity with this cut-off was 
37.6% and 98.3% instead, which illustrates the trade-off between sensitivity and 
specificity occurring whenever a cut-off level is used for categorization of 
continuous data. In this case, the OD450 values for the CIEP negative mink and 
4 Results and Discussion 
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CIEP positive mink overlapped in the ADV-G ELISA to a large extent (Figure 
12) which inevitably lead to a large number of false positive and false negative 
results. Consequently, the choice of cut-off will have a major impact on the 
estimations for sensitivity and specificity. 
 
Figure 12. The distribution of OD450 values in the ADV-G ELISA for CIEP negative and CIEP 
positive mink. The mean OD450 was 0.11 for the CIEP negative mink (SD=0.06), and 0.31 for the 
CIEP positive mink (SD=0.25). 
No details about the development of the ADV-G ELISA used in I (ADV-G 
ELISAUSA) have been published which makes further interpretations of the poor 
performance difficult. Another ADV-G ELISA has been developed in Denmark 
(ADV-G ELISADK) and reported a higher sensitivity but a lower specificity 
compared to CIEP for diagnosing ADV infection in serum and blood (Farid & 
Rupasinghe, 2016; Dam-Tuxen et al., 2014). The only scientific evaluation 
published of the performance of ADV-G ELISAUSA has been concerning the 
accuracy of ranking mink based on their estimated antibody level where the 
ADV-G ELISAUSA had the lowest accuracy compared to VP2 and the ADV-G 
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ELISADK (Farid & Rupasinghe, 2016). The poor performance of the ADV-G 
ELISAUSA could either be caused by the antigen per se or the optimization of the 
ELISA. In a previous study, the ADV-G antigen has been reported to be inferior 
to antigens based on ADV structural proteins (VP1 and VP2) for identifying 
mink with low as well as higher ADV antibody levels (Clemens et al., 1992). 
However, there are also differences in the operation procedure between the 
ADV-G ELISA and the VP2 ELISA in I which could have contributed to the 
different accuracies of the two tests. For instance, plasma samples diluted 1:100 
were used in the ADV-G ELISA compared to serum samples diluted 1:200 used 
in the VP2 ELISA. There are many possible ways to optimize the performance 
of an ELISA (Shan, 2010) . However, in I, we merely used previously developed 
systems and therefore we performed the ADV-G ELISA according to the 
instructions from the manufacturer. In the end, based on the poor performance 
of the test irrespective of the selected cut-off, the ADV-G ELISA was concluded 
to be substandard for detection of antibodies to ADV in the scrutinized 
population. 
For the VP2 ELISA, on the other hand, a single assay cut-off value was 
employed in I based on the mean OD450 value + 3 SD in accordance with a 
previous study of the VP2 ELISA (Knuuttila et al., 2009a), and was defined as 
OD450 = 0.14. Using this cut-off value, the estimated sensitivity of the VP2 
ELISA was 99.7% and the specificity was 98.3% which was comparable to the 
previous evaluation of the VP2 ELISA in Finnish mink where the sensitivity was 
established to 99% and the specificity was 97% (Knuuttila et al., 2009a). The 
overlap between CIEP positive and CIEP negative mink was considerably 
reduced for the VP2 ELISA (Figure 13) compared to the overlap for the ADV-
G ELISA, and therefore the sensitivity and specificity of the VP2 ELISA were 
less dependent upon the cut-off. Based on the superior sensitivity and specificity, 
the VP2 ELISA was concluded to be the preferred ELISA system for ADV 
diagnosis in the scrutinized mink population.  
52 
 
 
Figure 13. The distribution of OD450 values in the VP2 ELISA for CIEP negative (mean=0.04; 
SD=0.03) and CIEP positive mink (mean=0.90; SD=0.34) 
CIEP was chosen as the reference test since it has been the primary choice 
for routine diagnostics in many countries and therefore has been informally 
established as the gold standard test for ADV infection (Knuuttila, 2015; 
Uttenthal, 1992; Cho & Greenfield, 1978). However, CIEP cannot be regarded 
as a perfect reference test since CIEP itself have estimated to have a sensitivity 
of 79% - 99% and a specificity of 90% - 100% (Dam-Tuxen et al., 2014; 
Knuuttila et al., 2014; Aasted et al., 1986; Wright & Wilkie, 1982) and it has not 
been properly validated according to the OIE standards (Knuuttila, 2015). In 
addition, CIEP cannot be assumed to be conditionally independent from the two 
ELISA systems since they all measure antibodies (Georgiadis et al., 2003; 
Gardner et al., 2000). Therefore, estimations of the accuracy of the ELISA 
systems risk to be both flawed due to misclassifications and biased due to the 
dependence of the tests (OIE, 2014b; OIE, 2014a; Dohoo et al., 2009; Georgiadis 
et al., 2003; Gardner et al., 2000). One alternative to handle this statistically is 
through LCA (OIE, 2014a; Georgiadis et al., 2003; Staquet et al., 1981; Hui & 
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Walter, 1980), but unfortunately this was not performed in I. However, in this 
thesis, the data in I were re-analysed using Bayesian LCA. The results have not 
been compiled into a scientific paper but are presented below (Table 1). As the 
covariances between the three tests were low (<0.001), only the model assuming 
conditional independence using informative or uniform priors is presented 
below. In conclusion, estimations for sensitivity and specificity for the two 
ELISA systems were very similar to the sensitivities and specificities presented 
in I - especially the results from the model using uniform priors (which could be 
expected). 
 
Table 1. Posterior median and 95% posterior credibility interval (95% PCI) of populations specific 
prevalence, sensitivity and specificity obtained from latent class analysis, assuming conditional 
independence between the two ELISA systems the CIEP test, using informative or uniform priors. 
Results from the comparison between the two ELISAs and CIEP using CIEP as golden standard 
(results from I) is also presented. 
 
Informative priors Uniform priors Results in I 
 
Median 95% PCI Median 95% PCI 
 
      
Prevalence      
Herd A 0.94 [0.88; 0.98] 0.92 [0.86; 0.96] 0.92 
Herd B 0.92 [0.86; 0.96] 0.92 [0.86; 0.96] 0.93 
Herd C 0.89 [0.81; 0.94] 0.86 [0.78; 0.92] 0.86 
Herd D 0.89 [0.78; 0.95] 0.86 [0.73; 0.94] 0.84 
Herd E 0.03 [0.0009; 0.14] 0.03 [0.001; 0.13] 0.00 
      
Sensitivity      
CIEP 0.87 [0.84; 0.89] 0.99 [0.97; 1.00] Ref. 
VP2 ELISA 0.98 [0.96; 0.99] 0.99 [0.98; 1.00] 0.99 
ADV-G ELISA 0.76 [0.73; 0.79] 0.56 [0.51; 0.61] 0.54 
      
Specificity      
CIEP 0.95 [0.91; 0.98] 0.99 [0.93; 1.00] Ref. 
VP2 ELISA  0.98 [0.96; 1.00] 0.95 [0.85; 1.00] 0.98 
ADV-G ELISA 0.99 [0.99; 1.00] 0.88 [0.79; 0.95] 0.93 
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4.1.2 DBS ELISA 
In II, the VP2 ELISA system was further evaluated for detection of ADV 
antibodies in DBS. Initially, a DBS eluate dilution of 1:5 (corresponding to a 
serum dilution of 1:200) was used. Employing this dilution, 1,008 mink 
originating from an ADV seronegative farm had a mean OD450 = 0.15 (SD=0.07) 
with values ranging from 0.03 to 1.04. In total, 28 mink had OD450 values 
exceeding 0.28 (corresponding to the mean OD450 value +2 SD) and all these 
mink were re-evaluated with another test to confirm their disease status. The 
confirmatory test was PCR of the spleen and mesenteric lymph nodes or plasma 
CIEP and all the 28 mink were confirmed ADV negative. The increased OD450 
values were consequently regarded as background noise due to the use of whole 
blood eluted from DBS instead of serum. Through stepwise dilution, the DBS 
eluate dilution when all samples had an OD450 value < 0.28 was established to 
be 1:20 (corresponding to a serum dilution of 1:800). In a second step, using an 
eluate dilution of 1:20, mink from two ADV seronegative herds analysed for 
ADV antibodies had no suspected seropositive mink and a mean OD450 value of 
0.21 (SD=0.06) and 0.11 (SD=0.04), respectively. 
When evaluating the precision of the DBS VP2 ELISA, the repeatability in 
terms of mean intra-assay CV for the two consecutive days was 5.5% and 5.8%, 
respectively, and the reproducibility in terms of mean inter-assay CV was 
12.0%. Although the ELISA worked well, the variability could have been 
reduced further. One thing that could reduce the variability is a more 
homogenous antigen solution for the plate coating. Indeed, following this study, 
the risk of persistent precipitations in VP2 ADV antigen solution has been 
further decreased by an extra centrifugation both prior to delivery of the antigen3 
as well as in the lab prior to dilution of the antigen. In the end, our evaluation 
confirmed that antibodies to ADV can be detected in DBS eluates with a 
precision within the acceptable maximum CVs of 15% and 20%, respectively 
(Shan, 2010; United Nations Office on Drugs and Crime, 2009; OIE, 2008). The 
only sample with an inter-assay variability outside this range (CV=26.1%) had 
an OD450 value of 1.9 which is outside the optimal ELISA OD reading range and 
the sample would therefore have benefitted from further dilution in order to 
improve the estimation. However, seen from a clinical perspective this was not 
necessary as it does not make any practical difference for mink with such high 
OD450 values. 
The accuracy of the DBS VP2 ELISA in categorizing mink from a low-
prevalence herd as seropositive or seronegative was evaluated with CIEP as the 
reference gold standard test. The mean OD450 value was significantly (p<0.05) 
                                                        
3. Kirsi Aaltonen, personal communication 
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higher in the group with CIEP positive mink than in the group with CIEP 
negative mink. Through ROC analysis, the assay cut-off for seropositive mink 
was defined as OD450=0.15 which was comparable to the cut-off established for 
the serum VP2 ELISA in I. A cut-off based on the mean OD450 value + 2 SD of 
the mink from the ADV seronegative herds was also defined (OD450=0.30). The 
estimated sensitivities of the DBS VP2 ELISA for these cut-offs, were 97.3% 
and 89.2%, respectively, and the specificities were 93.2% and 97.7%, 
respectively, which were comparable to what had been reported from other 
evaluations of filter paper VP2 ELISA systems (Farid & Segervall, 2014; 
Knuuttila et al., 2014). Compared to the serum VP2 ELISA, the OD450 values 
for the CIEP negative mink and CIEP positive mink overlapped more for the 
DBS VP2 ELISA (Figure 14) and the trade between sensitivity and specificity 
was again more prominent. However, irrespective of the cut-off chosen the 
sensitivity and specificity of the DBS VP2 ELISA were lower than the 
performance of the serum VP2 ELISA demonstrated in I (sensitivity 99.7%; 
specificity 98.3%). This is most likely an effect of using blood instead of serum. 
One factor which might have improved the DBS VP2 ELISA could be to use 
another elution buffer for the extraction of the DBS; now only one elution buffer 
(PBS/Tween) was tested in II. In the end, the choice of cut-off depends on the 
aim with the test and whether high sensitivity or high specificity is most 
important to fulfil the purpose e.g. demonstrating disease-free status, eradication 
of disease, or estimating disease prevalence.  
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Figure 14. The distribution of OD450 values in the VP2 ELISA for CIEP negative (mean=0.10; 
SD=0.07) and CIEP positive mink (mean=0.64; SD=0.29).  
4.2 Evaluation of ELISA as a tool for determining AD 
progression 
A major focus in this project, was the capacity of the ELISA to quantitatively 
estimate the amount of ADV antibodies as an indirect measurement of AD 
progression. Categorization of mink into infected and non-infected was of 
subordinate importance. Using ELISA as a tool for quantitative determination, 
antibody stability over time is an important criterion since the sampling for 
serological screening of many thousand mink for AD typically extends over 
some time and in larger herds can be stretched over a couple of weeks. For mink 
with progressive AD, IgG antibodies can typically be detected a couple of weeks 
after infection (Farid et al., 2015; Bloom et al., 1994; Hadlow et al., 1985; 
Aasted et al., 1984a; Hadlow et al., 1983). The IgG levels gradually increase and 
level out after a couple of months (Bloom et al., 1994; Hadlow et al., 1983). For 
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mink with non-progressive AD, the IgG antibody levels will instead remain low 
or decrease with time following an initial increase. When using the estimated 
antibody level as a diagnostic tool to determine the AD status in mink based on 
their result at a single sampling occasion, it is therefore essential to secure that 
the estimated antibody level will not depend on the sampling order of the mink 
in the herd. In III part I, comparisons between the OD450 values in serum from 
mink sampled either on consecutive days or one week apart showed that the 
difference between different measurements were all within the predefined 
interval of equivalence based on the methodological variance in II (δ=±0.1 
OD450). It was therefore concluded that the measurements were equal and that 
antibody levels can be considered stable over a couple of weeks and thereby 
useful as a diagnostic tool. 
With the introduction of ELISA for measuring ADV antibodies, the 
possibility to improve the sampling method arose. The use of DBS instead of 
serum could facilitate both sampling as well as the preparations for analysis at 
the laboratory. Prior to the initiation of II, DBS had been introduced at some 
laboratories but the method had not yet been scientifically published. In II, the 
quantitative comparison of OD450 values for paired samples of serum and DBS 
revealed an overall good agreement (r= 0.90). The mean OD450 value in DBS 
was slightly higher than the mean OD450 value in serum (1.02 compared to 0.91). 
Considering these results, DBS was concluded to be a fully applicable 
alternative to serum for quantitative analysis of ADV antibodies.  
In the next step, the capacity of the DBS VP2 ELISA to work as an indirect 
quantitative measurement of AD progression was investigated through 
evaluation of the correlation between the DBS antibody level (expressed as the 
OD450 value) to the degree of hypergammaglobulinemia (expressed in terms of 
the A:γG ratio). Since the concentrations of antibodies and gamma globulins 
have been reported to depend on many factors such as the host, the virus strain, 
the total pathogen load and time after infection (McKenna et al., 1999; Aasted 
& Hauch, 1988; Porter et al., 1984a; Hadlow et al., 1983; Eklund et al., 1968), 
it has previously been argued that quantitative ELISA analysis for antibodies 
cannot replace a direct test for hypergammaglobulinemia (Cepica et al., 2012). 
However, in II, a moderate - strong correlation between the level of antibodies 
and the degree of hypergammaglobulinemia (rserum=-0.66 and rDBS=-0.81) as well 
as a moderate - high coefficient of determination (R2serum=0.47 and R2lnDBS = 0.66) 
for the regression models were demonstrated. Both the correlation as well as the 
association between the OD450 value and the A:γG ratio were generally superior 
for DBS than for serum samples from the same mink. The superiority of DBS 
compared to serum can reflect the significantly higher OD450 values in DBS than 
serum for diseased mink (A:γG <5) which were not found for non-diseased mink 
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(A:γG >5). This indicated that there were components in the blood of diseased 
mink that created a background in the ELISA that increased the OD450 values 
and improved the association with AD progression estimated as 
hypergammaglobulinemia. Consequently, the DBS VP2 ELISA was concluded 
to be preferable over serum VP2 ELISA as a quantitative tool for estimating the 
degree of hypergammaglobulinemia and identify diseased mink.  
Through ROC analysis, an OD450 value of 0.50 in the DBS VP2 ELISA was 
found to correspond to healthy mink (defined as having an A:γG >8) and a cut-
off at OD450 ≥0.83 in the DBS VP2 ELISA was found optimal to predict diseased 
mink (Figure 15). The sensitivity and specificity of the DBS VP2 ELISA to 
identify mink with hypergammaglobulinemia, using OD450 ≥0.83 as cut-off, 
were determined to 87.6% and 76.0%, respectively. From this, it was concluded 
that the DBS VP2 ELISA can be a fully applicable diagnostic tool for estimating 
AD progression of individual mink in the absence of any available direct 
diagnostic method for the A:γG ratio. 
 
Figure 15. The OD450 cut-off values for ADV infection and different stages of AD progression 
originally published in III. 
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The idea behind estimations of AD progression is to control AD through 
selection of non-diseased mink as breeding mink (Thomsen, 2016; Aronen, 
2011; Greenfield et al., 1973), and thereby minimize the number of mink which 
will develop clinical symptoms in the herd the following year. Traditionally, this 
selection has depended on the result from IAT, and the sampling strategy 
throughout the year have varied between different herds; while some farmers 
sample both in October prior to pelting and in February prior to mating, many 
mink farmers still only select their future breeders prior to pelting (Svensk Mink, 
2017). Due to this, it is also important to investigate whether the same mink will 
have a similar OD450 value irrespective of the sampling period. In III part II, 
comparisons between the OD450 values in DBS from mink sampled in October 
and February revealed a significantly higher median OD450 value in February 
than in October (0.72 compared to 0.58). Consequently, the proportion of mink 
categorized as seropositive (OD450 ≥ 0.15) was also higher in February than in 
October (90% compared to 83%). More than half of the mink (55%) that were 
seronegative in October had seroconverted until February while a small 
proportion (3%) of the mink that were seropositive in October were categorized 
as seronegative in February. In herds in areas where AD is endemic, estimating 
AD progression in terms of ELISA OD450 value has been suggested as a tool for 
grading mink during the selection of future breeding animals. In that process, 
variations in OD450 value with time would consequently lead to different 
estimations of the AD progression in the mink. In addition, in III part II, the 
correlation between the October and February samplings was only moderate 
(r=0.53) indicating that there is a risk that the grading order of the animals will 
vary between the two sampling occasions. Within a control program, this means 
that the time point of sampling mink will influence the selection of future 
breeders.  
To investigate how selection at the two different time points would affect 
which mink were selected, the AD progression was categorized and the AD 
status of each mink was compared between the two sampling occasions. The 
results (III part II) showed that 64% of the mink categorized as healthy (OD450 < 
0.50) during the October testing were categorized as healthy in February as well. 
Similarly, a majority of the mink (75%) that were categorized as non-diseased 
(OD450 < 0.83) during the October testing remained non-diseased until February. 
Of the mink categorized as non-healthy (OD450≥0.50) during the October testing, 
92% were categorized non-healthy in February as well while 8% were 
categorized as healthy in February. Similarly, 66% of the mink categorized as 
diseased (OD450≥0.83) during the October testing, were categorized diseased in 
February as well while 31% were categorized as ambiguous and 4% were 
categorized as healthy. One reason for the general increase in antibody level 
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between the two sampling occasions could be true disease progression, either in 
mink not infected in October or in infected mink experiencing a gradual increase 
of immunoglobulins typical of AD (An et al., 1978; Kenyon et al., 1963). 
Another possible explanation for the difference could be that the ADV antibody 
levels are showing similar seasonal changes as those that has been reported for 
gamma globulin concentrations in ADV infected mink (Bazeley, 1976). 
However, the correlation between the two sampling occasions was only 
moderate, indicating that the antibody levels in the individual mink were not 
affected in a similar way and that there may be other factors that affect the long-
term consistency in ADV antibody levels. For instance, a decreased antibody 
level between the two samplings could mirror “resistant” animals or animals 
with non-persistent infection (An & Ingram, 1978). Thus, mink with low to 
decreasing concentrations of antibodies to ADV could thereby be of interest to 
select for breeding. It could also be argued that the observed difference in 
antibody levels between October and February was caused by a methodological 
variance. However, the median absolute difference between the two samplings 
in III part II exceeded the predefined equivalence interval based on the 
methodological variance found in II (0.18 and 0.10, respectively) and the 
difference was concluded to be a real difference and not a consequence of 
methodological variation. 
4.3 Association between AD status and reproductive 
performance  
AD has previously been reported to have a negative impact on the 
reproductive performance (Reichert & Kostro, 2014; Segervall, 2011; Kangas & 
Smeds, 1983; Kangas, 1971). To investigate the association between AD status 
estimated with the DBS VP2 ELISA and the reproductive performance, the 
reproductive performance of the mink in IV was measured and expressed 
separately in terms of percentage of barren females and the mean litter size of 
the non-barren female mink. For the single herd scrutinized in IV pilot, the 
percentage of barren females (both primiparous and older female mink) was 31% 
and the mean litter size of the non-barren female mink was 5.2 (SD=2.0). In IV 
follow-up, the mean percentage of primiparous barren females for the four herds 
scrutinized was 14% (range: 13-19%) and the mean litter size of the non-barren 
female mink was 5.9 (range: 5.6 – 6.1). In all herds in IV pilot and IV follow-up, the 
percentage of barren females was higher than the recorded mean percentage of 
barren females for Swedish ADV infected herds (11.5% in 2012 (n=68) and 
8.8% in 2013 (n=64) (Svensk Mink, 2017)). A selection bias can be one possible 
explanation for the generally increased percentage of barren females in the 
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scrutinized herds since farmers experiencing a more progressive ADV infection 
in their herd can be more likely to seek advice and enrol to the AD control 
program. However, the large percentage (20 %) of non-diseased barren females 
in IV pilot is noteworthy, and other un-diagnosed factors could have contributed 
to an overall increased percentage of barren females. Such factors can for 
instance be nutrition in terms of the amount of energy and nutrients, the feed 
quality, as well as the feeding strategy (Børsting, 1998; Tauson, 1992).  
In IV, both AD status and the age of the female mink were significantly 
associated with both being barren and litter size. Diseased mink, defined as 
having an OD450 value > 0.8 before mating, had a higher risk of being barren 
compared to non-diseased female mink in an interaction with the age in of the 
female mink in IV pilot. The risk of being barren was 2.6 times higher among 
primiparous diseased female mink compared to the primiparous non-diseased 
female mink while for the older female mink, no significant difference in 
percentage of barren females due to the AD status was found. For both the 
diseased as well as non-diseased female mink, the percentage of barren females 
and the risk for being barren was significantly higher for primiparous compared 
to older female mink. In IV follow-up, when only primiparous mink were 
scrutinized, being barren was significantly associated with the AD status 
although the risk of being barren for diseased mink (OR=1.6) was lower than in 
IV pilot. One possible reason for this difference in risk could be that mink selected 
as breeders in the IV follow-up had a lower mean antibody level (OD450= 0.5 in IV 
follow-up compared to OD450=1.0 in IV pilot) indicating that mink with the highest 
antibody levels had been de-selected as breeders by the farmer prior to mating 
to a larger extent than in IV pilot. Due to this, the mean antibody level of the 
diseased mink was lower and consequently, a more limited negative effect on 
reproductive performance could be expected.  
Regarding litter size of the non-barren female mink, no significant 
association between the litter size of the non-barren female mink and the AD 
status was found in IV pilot. However, in IV follow-up when more herds were 
scrutinized, the effect of being diseased compared to non-diseased was a 
reduction in litter size by 5%. Thus, the results in IV agreed with earlier studies 
reporting smaller litter sizes as well as increased early kit mortality in diseased 
compared to non-diseased/healthy female mink (Reichert & Kostro, 2014; 
Kangas & Smeds, 1983; Kangas, 1971). Age was also associated with litter size 
of the non-barren female mink where older female mink had approximately 5% 
larger litter sizes compared to the primiparous female mink (IV pilot), which 
agreed with previous reports (Dziadosz, 2010; Lagerkvist, 1992). However, a 
bias in the selection of breeding female mink could also have contributed to the 
results in IV. Older female mink are more likely to perform better since they 
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have been selected due to a high reproductive performance during the previous 
year, and they may have had a superior resistance to AD which also could have 
influenced the reproductive performance.  
In IV, the colour type of the mink was also associated with the reproductive 
performance, which previously has been reported by others (Seremak, 2013; 
Brzozowski et al., 2012; Demontis et al., 2011; Felska & Sulik, 2000). A higher 
percentage of barren females and a lower mean litter size of the non-barren 
female mink for the Hedlund white female mink than for the brown female mink 
was observed in IV pilot. In IV follow-up, significant differences between colour 
types within the same herd could also be observed even though the superior 
colour types varied between different herds. In addition, in IV follow-up when four 
different herds were scrutinized, the observed mean percentage of barren 
females for the four herds ranged from 13% to 19% and the observed mean litter 
size of the non-barren female mink ranged from 5.6 to 6.1 with statistically 
significant differences between some of the herds. The model in IV follow-up was 
therefore adjusted for both herd and colour type of the mink. However, the 
influence of colour type and herd effects were not further evaluated since the 
main aim of this project was to evaluate the influence of the AD status on the 
reproductive performance. 
In conclusion, disease status of the female mink had an impact on the 
reproductive performance in IV and can therefore be a subject for a control 
program. However, it is important to be consistent when registering the 
reproductive performance in order to facilitate comparisons between different 
countries as well as between different herds. Previously, the mean litter size per 
mated female mink (including both barren and non-barren female mink) has 
commonly been reported (Segervall, 2011; Lagerkvist, 1992; Joergensen, 
1985b; Kangas & Smeds, 1983; Kangas, 1971), and has been traditionally used 
among farmers (Svensk Mink, 2017). The mean litter size per mated female 
mink is a joint measure combining two different processes, i.e. being barren and 
litter size of the non-barren female mink, that were differently associated with 
the estimated A:γG ratio in IV. Therefore, in order improve an AD control 
program, there are advantages of reporting both the percentage of barren females 
as well as the litter size of the non-barren female mink separately. In IV, the 
effect of disease on the reproductive performance was mainly an effect on the 
percentage of barren females although a slightly negative effect on the litter size 
was observed in IV follow-up. Further, the time at which the number of kits are 
counted can influence the reported reproductive performance. In the present 
project, litter size was defined as the number of kits alive at three weeks post-
partum which has previously been used in fur animal breeding programs and in 
research (Kempe & Strandén, 2016; Hansen et al., 2010; Lagerkvist, 1992). 
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However, this measure is also a joint measure combining the litter size at 
parturition with the pre-weaning survival rate. Due to this, the true percentage 
of barren females and the pre-weaning mortality are often unknown. Certainly, 
litter size at birth and pre-weaning mortality can be affected separately by ADV 
and the reported effect in IV on the reproductive performance could have been 
different if we had counted the number of kits earlier.  
4.4 Suggested strategies to improve the reproductive 
performance 
The overall aim of this thesis was to develop strategies to reduce the impact on 
welfare and reproduction in mink in ADV endemic areas using estimation of 
ADV antibodies as a tool. Knowledge that that the OD450 value in the DBS VP2 
ELISA was accurate for diagnosing ADV infection in the scrutinized population 
(II), stable in the short-term (III), highly correlated to the level of 
hypergammaglobulinemia (II), significantly associated to the reproductive 
performance (IV), quick to perform and can be offered at a reasonable price all 
make the DBS VP2 ELISA a suitable tool to use for disease control. Based on 
this, a suggested strategy to improve the reproductive performance is presented 
below.  
4.4.1 Categorizing mink based on AD progression 
When selecting future breeders, it is important to preserve the magnitude of the 
breeding stock and at the same time create space for genetic selection for 
desirable traits such as temperament, pelt quality, body size, and litter size 
(Joergensen, 1985b). In AD endemic areas, one way to control the disease is 
through selection of suitable breeding mink and this selection has traditionally 
depended on the result from IAT. In II, the alternative to use of the DBS VP2 
ELISA instead of IAT to categorize mink based on AD progression was 
presented (Figure 15). Depending on the selected cut-off value, the mink could 
either be categorized into seropositive/seronegative, healthy/non-healthy, or 
diseased/non-diseased and at each sampling time, any of these categorizations 
could possibly be used. However, controlling AD and preserving the size of the 
breeding stock at the same time can be challenging in herds with a high 
prevalence of ADV infected mink. In this project, the proportions of ADV 
infected mink of the herds in I were between 85% - 93%, according to the results 
obtained in the serum VP2 ELISA and the herds in IV between 78% - 95% 
according to the results obtained in the DBS VP2 ELISA. As will be illustrated 
below, this high prevalence of infected mink makes it impossible to select only 
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non-infected mink for breeding. Focusing on AD progression instead, the 
proportion of diseased mink (OD450 value > 0.8), was 60% in the single herd in 
IV pilot with a significant difference between primiparous mink (73%) and older 
mink (48%). In IV follow-up, including primiparous mink from four herds, in 
average 19% of the mink were categorized as diseased with a significant 
difference in proportion of diseased mink between different herds (8% - 51%). 
To illustrate the effect of the selected cut-off on the number of potential 
future breeding female mink in a herd, a hypothetical example was created in IV 
and further modified here (Table 2). The example is based on two samplings per 
year, i.e. in October and February, where the same cut-off is used for the two 
samplings. Using 14% barren females and 5.9 kits per non-barren female mink 
(as was reported in IV) in the calculations, a breeding result at three weeks post-
partum of 5.1 kits per mated female mink can be expected. Hence, a farm with 
1,000 female breeders, will deliver approximately 2,550 new potential female 
breeders (when the calculated number of female kits in a litter is 50%). Together 
with the initial 1,000 female breeders, the total number of future potential 
breeders is then approximately 3,550. However, due to normal mortality in the 
herd (Svensk Mink, 2017; De Rond. & Kleyn Van Willigen, 2012; Møller, 2011; 
Clausen, 2006), a loss of approximately 5% of the mink can be expected from 
three weeks post-partum until pelting. In this example, 177 female mink can 
therefore be expected to die throughout the production year and 3,373 female 
mink remaining for grading and ADV sampling at the end of October.  
Although Table 2 is based on only one publication (III), it indicates that not 
only culling all seropositive female mink but also all non-healthy female mink 
may lead to too few female mink left to preserve the size of the breeding stock 
in herds with a high prevalence of AD positive mink. By culling only mink 
categorized as diseased, around 40% of the female mink would still be potential 
breeding animals at three weeks post-partum, which is approximately 1.5 times 
the number of female mink needed for breeding and leaves freedom to select for 
other traits.  
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Table 2. Hypothetical example of how the number of potential future breeding female mink is 
affected by the choice of cut-off in the DBS VP2 ELISA. The figures are extrapolated and modified 
from the results originally published in III and IV.  
 
     
  Selection threshold 
  
Seronegative 
(OD450 <0.15) 
Healthy 
(OD450 < 0.50) 
Non-diseased 
(OD450 <0.83) 
     
Size of female breeding stock (n) 1000 1000 1000 
New female mink born (n) 2550 2550 2550 
Total number of female mink 
at 3 w p.p 
(n) 3550 3550 3550 
Remaining female mink at the 
end of October 1  
(n) 3373 3373 3373 
     
October     
Percentage of female mink 
above cut-off 
(%) 832 583 393 
Female mink potentially culled 
due to high OD450 value 
(n) 2800 1956 1315 
Potential breeding female 
mink remaining 
(n) 573 1417 2058 
     
February     
Percentage of female mink 
above cut-off 
(%) 553 363 253 
Female mink potentially culled 
due to high OD450 value 
(n) 315 510 514 
Potential breeding female 
mink remaining 
(n) 258 907 1544 
     
Female breeders required for 
the next season 
(n) 1000 1000 1000 
Balance (basis for selection) (n) -742 -93 +544 
1 Expected mortality from three weeks post-partum to pelting of up to 5% (Svensk Mink, 2017; De Rond. & Kleyn Van 
Willigen, 2012; Møller, 2011; Clausen, 2006) 
2 Based on the results in III and IV 
3 Based on the results in IV 
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Besides preserving the size of the breeding stock and create space for genetic 
selection for desirable traits, it is essential to minimize the risk of poor 
reproductive performance in ADV positive herds. A quantitative test for ADV 
antibodies creates a possibility to control AD. Based on the results in IV, 
removal of primiparous diseased female mink from the breeding stock before 
mating in February was concluded to be beneficial for the reproductive 
performance of the herd by minimizing the risk for barren females. There is a 
potential advantage of choosing a higher cut-off for the first sampling in October 
since this will create more space for selection for other desirable traits, and at 
the same time decreases the risk of culling mink that will go from a higher to a 
lower antibody level between the two sampling occasions i.e. mink that most 
probably had an immune system handling ADV without developing 
hypergammaglobulinemia. At farm level, this can either be done by an arbitrary 
chosen higher cut-off in the ELISA adjusted to the farm-specific distribution of 
OD450 values. Alternatively, IAT can be chosen for the first screening even 
though it is likely to result in a more unspecific selection (Porter et al., 1980; 
Gorham et al., 1976; Greenfield et al., 1973). Employing a higher cut-off value 
and keeping more mink will be a balance act with an increased risk of viral 
spread from seropositive mink. It should, however, be mentioned that 
irrespective of the test in October, it was the disease status before mating that 
was associated with the reproductive performance in IV.  
4.4.2 Further discrimination between more or less diseased mink  
In IV the mean OD450 value varied between the different herds, and there is a 
risk that not all mink with an OD450 value > 0.8 can be removed from the 
breeding stock in herds with a higher mean value without decreasing the size of 
the breeding stock and impede selection for other economically important traits. 
It has therefore been discussed whether the OD450 value can be used as a 
continuous variable instead of categorical as was presented in IV. To illustrate 
the epidemiological rationale behind such a strategy, an extended investigation 
of the reproductive performance of the diseased mink (OD450 value > 0.8) was 
performed for the four herds originally included in IV follow-up. The results of this 
extended investigation have not been compiled into a scientific paper but are 
presented below.  
In order to visibly assess the linearity between the OD450 and the reproductive 
performance, the OD450 value in February and the litter size for all 10,638 female 
mink (both barren and non-barren) were plotted using the” lowess” command in 
Stata (Figure 16). As is illustrated in the graph, the net reproductive performance 
per mated female mink was relatively constant for mink with an OD450 value ≤ 
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0.8. Based on this data, there is no evidence of an advantage of using a lower 
DBS VP2 ELISA cut-off value nor of sorting non-diseased mink based on their 
OD450 value. In contrast, there seems to be a possible negative association 
between the OD450 value and the reproductive performance in mink with OD450 
values > 0.8.  
 
 
Figure 16. The litter size and the OD450 value in February for the 10,638 female mink originally 
included in IV follow-up. The litter size of each mink is marked as a dot in the graph and the lowess 
curve represents the mean number of kits per mated female mink for each OD45O value.  
When further investigating the association between the reproductive 
performance and different OD450 values of the diseased mink, there seemed to 
be two different risk classes: (i) OD450 values 0.9 – 1.1, and (ii) OD450 values ≥ 
1.2 which both were significantly associated with an increased risk of being 
barren. (Table 3). For practical reasons, the female mink may be subdivided into 
three categories: non-diseased (OD450 ≤ 0.8), diseased+ (OD450: 0.9 – 1.1), and 
diseased++ (OD450 ≥ 1.2). To validate this categorization, another logistic 
regression model was made using these three categories and the average 
predicted percentage of barren females was estimated for each category (Table 
4). For the litter size of the non-barren female mink, an OD450 value ≥ 1.2 was 
significantly associated with a decreased litter size (Table 3). Using the same 
three categories for the OD450 values as for the risk of being barren above, only 
the diseased++- category was significantly associated with a decreased litter size 
of the non-barren female mink (Table 4).  
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Table 3. The odds ratio (OR) for being barren, the predicted percentage of barren females, the 
incidence risk ratio (IRR) and predicted litter size per non-barren female mink for different DBS 
VP2 OD450 values for the models in addendum using the data from the 10,638 primiparous mink 
originally investigated in IV.  
 
Logistic model Poisson regression model 
 
OR p-value 
Predicted 
percentage of 
barren females 
(95% CI) 
IRR p-value 
Predicted 
litter size per 
non-barren 
female mink 
(95% CI)) 
OD450 value       
≤ 0.8 Ref. Ref. 13 (12;13) Ref. Ref. 5.9 (5.9-6.0) 
0.9 1.3 0.05 16 (13; 19) 0.97 0.21 5.8 (5.6-6.0) 
1.0 1.6 <0.001 19 (15; 22) 0.99 0.74 5.9 (5.7-6.1) 
1.1 1.4 0.04 17 (13; 21) 0.96 0.12 5.7 (5.4-6.0) 
1.2 2.1 <0.001 24 (18; 29) 0.90 0.001 5.3 (5.0-5.7) 
1.3 2.4 <0.001 26 (20; 31) 0.88 <0.001 5.2 (4.9-5.5) 
≥ 1.4 2.2 0.004 24 (14; 33) 0.87 0.013 5.2 (4.6-5.7) 
Herd       
1 Ref. Ref. 15 (13;17) Ref. Ref. 6.0 
2 0.9 0.19 14 (12;15) 0.99 0.69 6.0 
3 1.1 0.30 17 (15;19) 0.93 <0.001 5.6 
4 0.8 0.03 13 (12;14) 0.98 0.17 5.9 
Colour       
812 Ref. Ref. 15 (14;16) Ref. Ref. 5.8 
813 0.9 0.08 13 (12;15) 1.07 <0.001 6.2 
814 0.7 <0.001 11 (9;12) 1.03 0.03 6.0 
Intercept 0.2   5.98   
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Table 4. The odds ratio (OR) for being barren, the predicted percentage of barren females, the 
incidence risk ratio (IRR) and predicted litter size per non-barren female mink for three categories 
of diseased mink in addendum using the data from the 10,638 primiparous mink originally 
investigated in IV.  
 
Logistic model Poisson regression model 
 OR p-value Predicted 
percentage of 
barren females 
(95% CI) 
IRR p-value Predicted 
litter size per 
non-barren 
female mink 
(95% CI)) 
Disease status       
Non-diseased Ref. Ref. 13 (12;13) Ref. Ref. 5.9 (5.9; 6.0) 
Diseased+ 1.4 <0.001 17 (15;19) 0.98 0.11 5.8 (5.7;6.0) 
Diseased++ 2.3 <0.001 25 (21; 28) 0.89 <0.001 5.3 (5.1;5.5) 
Herd       
1 Ref. Ref. 15 (13;17) Ref. Ref. 6.0 (5.9;6.2) 
2 0.9 0.21 14 (12;15) 0.99 0.67 6.0 (5.8;6.1) 
3 1.1 0.26 17 (15;19) 0.93 <0.001 5.6 (5.4;5.7) 
4 0.8 0.03 13 (12;14) 0.98 0.19 5.9 (5.8;6.0) 
Colour       
812 Ref. Ref. 15 (14;16) Ref. Ref. 5.8 (5.7;5.9) 
813 0.9 0.08 13 (12;15) 1.07 <0.001 6.2 (6.1;6.4) 
814 0.7 <0.001 11 (9;12) 1.03 0.03 6.0 (5.8;6.1) 
Intercept 0.2   5.98   
 
In conclusion, mink with an OD450 value in the DBS VP2 ELISA between 0.9 
and 1.1 had a slightly increased risk of being barren (OR=1.4) but there was no 
evidence of any effect on the litter size of the non-barren female mink. For mink 
with an OD450 value ≥ 1.2, however, there was a more prominent risk of being 
barren (OR=2.3) in addition to an expected decreased litter size of the non-barren 
female mink of approximately 11% compared to non-diseased female mink. This 
implies that diseased mink can further be discriminated categorically if needed 
to facilitate selection of future breeders in herds with a high mean DBS VP2 
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OD450 value. The results from this limited material shows no evidence of a true 
linear relationship between the reproductive performance and the OD450 value. 
Therefore, the use of the OD450 value as a continuous variable in AD control 
programs still needs to be validated.  
4.4.3 Concluding remarks 
In conclusion, disease status of the female mink had an impact on the 
reproductive performance in IV and for herds with a low percentage of diseased 
mink, it can be possible to select for desirable traits and at the same time cull all 
diseased mink. In herds with a higher percentage of diseased mink, however, 
culling all diseased mink can have a negative impact on the genetic selection for 
other traits due to the impeded size of the breeding stock by selection for AD 
status. In such herds, there are indications that the negative impact on the 
reproductive performance can be limited by culling mink based on the three 
disease categories presented above.  
Today, the VP2 ELISA has been implemented as a tool for selection of 
breeders in several Swedish herds but due to lack of available large-scale 
national diagnostic possibilities, many mink farmers still use IAT as the 
preferred tool for AD screening. Screening mink with for ADV antibodies with 
the VP2 ELISA can be expected to identify mink with hypergammaglobulinemia 
at an earlier stage and have the potential to improve both welfare as well as 
reproductive performance when employed at strategic time points throughout 
the production year. Therefore, it would be desirable with a future coordinated 
national strategy for the control of AD in Sweden based on the current 
knowledge presented in this thesis. 
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This work has generated increased knowledge about serodiagnosis of ADV 
infection and AD in Swedish mink including suggested strategies to reduce the 
impact of AD on reproduction in mink in endemic areas. Specific conclusions 
of the projects were: 
 
➢ The ELISA system based on VP2 antigen detected ADV antibodies with high 
sensitivity and high specificity when compared to CIEP. In contrast, the 
ELISA system based on ADV-G antigen did not perform as well and had a 
low sensitivity compared to CIEP. 
➢ The adaptation of the VP2 ELISA to detect antibodies to ADV in dried whole 
blood eluted from filter paper (DBS) had a preserved high sensitivity and 
specificity when compared to CIEP. 
➢ ADV antibody levels in mink were stable over a period of two weeks which 
correspond to the time that can be needed to sample all mink in large herds.  
➢ ADV antibody levels estimated with the VP2 ELISA in DBS correlated well 
to the antibody levels and to the gamma globulins levels in serum. The 
correlation and association between the antibody level and the level of 
gamma globulins were generally superior for DBS compared to serum 
samples from the same mink, and the use of DBS VP2 ELISA was therefore 
concluded to be the preferable indirect method for estimating AD progression 
in mink. 
➢ ADV antibody levels in samples collected from the same mink four months 
apart differed significantly, indicating non-consistency over time, and further 
studies are needed to follow the alterations in antibody levels throughout the 
production year.  
➢ In primiparous mink, the risk of being barren was associated with the AD 
status prior to mating with a higher risk in diseased mink than in non-diseased 
mink. In addition, there was an association between the litter size of 
primiparous non-barren female mink and the AD status prior to mating. In 
5 Conclusions  
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diseased mink, the litter size was reduced by approximately 5 % compared 
to non-diseased mink. Selection of primiparous female mink with low OD450 
values for breeding can therefore reduce the risk of reduced reproductive 
performance. 
➢ In older mink, no association between the risk of being barren and AD status 
prior to mating was found. The litter size of non-barren female mink was 
approximately 5 % larger than for primiparous mink irrespective of disease 
status. However, it should be kept in mind that these mink had been selected 
due to good reproductive performance during the preceding production year.  
➢ Herd and colour type of the female mink influenced both the percentage of 
barren females and the litter size of the non-barren female mink.  
➢ By categorizing mink into three different categories based on the ADV 
antibody level, the control of AD in herds with high mean antibody levels 
can be facilitated.  
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For many years, the only way to control AD was by eradication of either CIEP 
positive mink or IAT positive mink, which reduces the flexibility in control 
programs. During the past decade, quantitative measurement of AD progression 
has grown in popularity as a method to select future breeding animals. However, 
control of AD in endemic areas has not previously been the focus of research, 
and scientific evaluations of quantitative ELISA as a method to control AD have 
therefore been sparse. The information provided in this thesis can be used to 
improve control programs based on quantitative ELISA systems which would 
contribute to increased welfare, reproductive performance and production 
economy in areas where AD is endemic. However, there are still many 
challenges ahead.  
The strategy presented in this thesis is only based on one study (IV) and in 
the future, it would be interesting to verify the results in a larger number of 
randomly selected herds. Similar strategies have been introduced and 
implemented in other countries with endemic AD, such as the Netherlands and 
Canada. However, these works have not yet been properly statistically evaluated 
and published despite convincing clinical experience. Consequently, it would be 
valuable to confirm the findings in IV by including herds in different AD 
endemic countries into future statistical modulations. 
Based on this thesis, several research gaps can be identified and new 
questions have been generated:  
Host factors 
➢ More knowledge about the variations in ADV antibody levels throughout the 
production year is needed in order to optimize the strategic time points when 
mink should be sampled in order best predict the future reproductive 
performance.  
6 Future perspectives 
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➢ The number of kits as well as kit related parameters (birth weight, growth, 
and early mortality) ought to be monitored and recorded at different times 
post-partum e.g. at birth, at 3 w and at weaning with the aim to evaluate the 
effect of the female antibody level on several different aspects of 
reproductive performance.  
➢ Simulations of the reproductive performance of mink have been presented 
for ADV seronegative mink including parameters such as body size 
(Gautason et al., 2016). In the future, it would be interesting to mimic this 
simulation for ADV positive mink to further improve the models presented 
in this thesis.  
Viral factors 
➢ There is a large variety of ADV strains circulating in the mink populations 
and it has previously been shown that the virus strain affect the progression 
of AD (McKenna et al., 1999; Hadlow et al., 1983; Eklund et al., 1968). 
Therefore, it would be interesting to include viral strains into the statistical 
models with the aim to evaluate whether the association with reproductive 
performance differs between different viral strains.  
Breeding factors 
➢ In this project, the focus was on the antibody level of the female mink. In the 
future, it would also be interesting to evaluate the association between the 
levels of ADV antibodies in male mink during the months prior to mating, 
and reproductive performance.  
➢ In this project, the follow-up period for the evaluations of the effect of high 
and low ADV antibody levels was short, and it would be interesting to follow 
the reactions to ADV infection through future generations both in relation to 
the female as well as the male AD status.  
➢ As the reproductive performance of older female mink was superior to that 
of primiparous female mink, it is tempting to increase the number of older 
female mink in the breeding stock. With an improved reproductive 
performance of juvenile mink, a larger percentage of these primiparous mink 
can be considered as breeding animals the next season (i.e. be older female 
mink the following year) and less female breeders will need to be recruited 
from the juvenile mink (i.e. less primiparous female mink in the breeding 
stock). Consequently, the mean age of the female breeding stock will 
increase.  
➢ An improved reproductive performance of primiparous female mink will also 
increase the total number of potential female breeders which in turn creates 
75 
 
space to select for other desirable traits than AD status, which in turn will 
improve the overall productivity of the herd. To further explore the benefits 
of ELISA for improving productivity in terms of other parameters, studies on 
the relationship between the number of available female mink to select from 
and selection for other desirable traits are of great importance.  
Technical factors 
➢ Increased knowledge and awareness of the value of validation of diagnostic 
tests for AD are desirable. Today, there exist several different tests which are 
available to mink farmers in different countries. It is essential to ensure that 
every method used, for research purposes as well as commercial purposes, 
have been validated for the purpose it is intended for i.e. for qualitative or 
quantitative ADV antibody estimation. Ideally, each method should be 
accompanied with an easily accessible research-based report on the accuracy 
as well as the precision of the test.  
➢ Registration of farm related data for Swedish mink such as mortality, 
reproductive performance and disease incidence is relatively novel to the 
Swedish mink farmers. The quality of the registered data as well as the 
usability of the data would benefit from more automated computer based 
systems.  
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Plasmacytos kallas även aleutiansjukan från engelskans Aleutian disease (AD). 
AD är en sjukdom som drabbar mårddjur och är en sjukdom av stor betydelse 
för minkar världen över. Sjukdomen orsakas av infektion med plasmacytosvirus 
(på engelska Aleutian disease virus; ADV). ADV har en lång överlevnadstid 
utanför sitt värddjur och anses vara ett mycket smittsamt virus som lätt överförs 
direkt från mink till mink eller indirekt via redskap, foder m.m. Viruset smittar 
även från moderdjur till avkommorna via moderkakan.  
Det finns två olika former av sjukdomen. Hos unga minkar utan medfött 
antikroppsskydd leder infektionen till en akut lunginflammation med andnöd 
och hög dödlighet. Hos valpar med medfött antikroppsskydd och hos äldre 
minkar orsakar viruset självt endast en begränsad skada på kroppens celler och 
det som orsakar sjukdomen är istället minkens eget immunförsvar. Genom en 
komplicerad mekanism lyckas viruset undslippa immunförsvaret och 
infektionen blir istället kronisk. Den kroniska närvaron av virus i kroppen leder 
till en fortsatt stimulering av immunförsvaret vilket skapar en ond cirkel. 
Successivt bildas mer och mer antikroppar (hypergammaglobulinemi) av en 
ökande mängd antikroppsbildande plasmaceller (plasmacytos). Antikropparna 
binder till viruspartiklar i kroppen och tillsammans bildar de komplex som 
ansamlas i de mindre blodkärlen och fastnar i olika organ i kroppen t.ex. njurarna 
och levern. Detta kommer med tiden att störa organens funktion vilket ger 
symtom som nedsatt aptit, viktminskning, blodbrist, nedsatt 
fortplantningsförmåga, njursvikt och förhöjd dödlighet. Inkubationstiden från 
smitta till synliga symtom är lång och kan vara upp till ett par år. På gårdsnivå 
har sjukdomen betydelse både för djurens välfärd och för produktionsekonomin.  
Eftersom det är minkens eget immunförsvar som orsakar 
sjukdomssymptomen så finns det inget vaccin som kan skydda mot sjukdomen. 
Än så länge finns det inte heller någon fungerande, prisvärd, effektiv behandling 
och sjukdomen hanteras istället med hjälp av olika bekämpningsprogram. 
Traditionellt har bekämpningsprogram i områden där plasmacytosviruset är 
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mindre vanligt bestått i att försöka utrota sjukdomen med hjälp av s.k. ”stamping 
out” där alla minkarna på gården avlivas och ersätts med friska djur efter en 
omfattande sanering av gården. I och med att viruset är så motståndskraftigt och 
smittsamt så är dock ”stamping out” förenat med risker för återinfektion. I 
områden med endemisk plasmacytos (ständig närvaro av plasmacytos) har 
”stamping out” visat sig vara svårare och istället söks det kontinuerligt efter nya 
alternativ för bekämpning av sjukdomen. 
För att påvisa plasmacytos hos levande djur tas blodprov. Traditionellt har 
blodproverna undersökts med motströmslektrofores (CIEP) men de senaste åren 
har en nyare metod blivit en alltmer populär metod för att påvisa antikroppar 
mot plasmacytos, Metoden kallas ELISA och har fördelen att den inte bara kan 
påvisa om minken är infekterad eller inte utan även kan mäta mängd antikroppar 
hos de infekterade minkarna. Detta är viktigt eftersom mängden antikroppar ökar 
ju längre sjukdomen fortskrider. Därför har bestämning av mängden antikroppar 
föreslagits som ett indirekt mått på hur långt sjukdomen fortskridit hos minken. 
För gårdar där smittan inte kan utrotas så kan bestämning av djurens 
antikroppsmängd vara grunden till en alternativ bekämpning av AD. Genom en 
riktad provtagning innan avelssäsongen kan man identifiera djur som trots att de 
är smittade inte har utvecklat AD och därför är lämpliga att använda som 
avelsdjur. Denna metod för att välja ut lämpliga avelsdjur har inspirerat till 
frivilliga kontrollprogram i exempelvis Kanada och Nederländerna och är ett 
tilltalande alternativ för plasmacytosbekämpning även i Sverige.  
Innan det här doktorandarbetet påbörjades saknades vetenskapliga studier 
som visade att mängden antikroppar som uppmättes med ELISA också gav ett 
mått på graden av sjukdom hos mink och hur detta mått på graden av sjukdom 
påverkar viktiga egenskaper såsom fortplantningsförmågan. Det övergripande 
målet med det här doktorandarbetet var därför att öka kunskapen om diagnostik 
av plasmacytos hos svenska minkar för att ge ett redskap som kan användas i en 
strategi för att kontrollera plasmacytos i områden där sjukdomen förekommer 
endemiskt såsom i Sverige.  
 
Den här avhandlingen baseras på fyra vetenskapliga arbeten (I – IV). Den första 
studien, I, genomfördes på fem svenska minkgårdar med målet att jämföra två 
olika ELISA-system för analys av plasmacytosantikroppar i minkblod (plasma 
eller serum) med CIEP. Vi valde att jämföra ELISA-systemen med CIEP då 
CIEP anses vara det test som är bäst (den s.k. gyllene standarden för att påvisa 
plasmacytosantikroppar). Det visade sig att det ELISA-system som baserades på 
VP2 protein påvisade antikroppar mot ADV hos svenska minkar med hög 
tillförlitlighet. 
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I den andra studien, II, låg fokus på att förenkla provtagningen och 
analysförfarandet genom att använda intorkat blod filterpapper (dried blood 
spots; DBS) istället för blod i kapillärrör. Genom en viss anpassning av VP2 
ELISA-systemets utförande så kunde plasmacytosinfekterade djur särskiljas 
från plasmacytosfria djur med hög tillförlitlighet på gårdar med låg förekomst 
av infekterade djur. Vid jämförelse mellan den uppskattade antikroppsmängden 
i serum och den i DBS så var överensstämmelsen hög även om de uppmätta 
värdena i genomsnitt var högre i DBS än i serum. Vid vidare analys visade det 
sig att statistiskt säkerställda skillnader av betydelse mellan DBS och serum 
endast fanns hos de djur som hade förhöjd nivå av gammaglobuliner i blodet 
(uttryckt som kvot mellan albumin och gammaglobuliner i blodet). För minkar 
med normala nivåer av gammaglobuliner kunde inga skillnader påvisas. När den 
uppskattade mängden av plasmacytosantikroppar jämfördes med mängden 
gammaglobuliner i blodet så var överenstämmelsen högre för DBS än för serum.  
I den tredje studien, III, undersöktes stabiliteten av den uppmätta 
antikroppsmängden över tid. I den första delen av studien konstaterades att 
antikroppsmängden i blodprov som tagits upp till två veckors mellanrum stämde 
väl överens med varandra. Resultaten visade att antikroppsmängden uppmätt 
med VP2 ELISA därför var tillförlitligt för att rangordna minkar på en gård även 
om provtagningen sträcker sig över ett par veckor. I den andra delen av studien 
jämfördes antikroppsmängden vid två olika provtagningstillfällen med fyra 
månaders mellanrum; den första i samband med det stora urvalet av avelsdjur 
strax innan pälsningen på hösten (i oktober) och den andra strax före parningen 
(i februari). Här var skillnaderna i antikroppsmängd mellan de två olika 
provtagningarna större och antikroppsmängden var signifikant högre i februari 
än i oktober. Överenstämmelsen mellan höst- och vårprovtagningen var låg och 
vidare studier behövs därför för att utreda betydelsen av när antikroppsmängden 
bäst bör mätas i ett kontrollprogram för AD.  
Plasmacytosens påverkan på avelsresultatet kan visa sig både som en ökad 
andel gallhonor (d.v.s. honor som inte får några valpar) och som en minskad 
kullstorlek bland de honor som får valpar. På gårdsnivå uttrycks detta 
tillsammans som kullstorleken per parad hona d.v.s. antalet valpar utslaget på 
alla honor inklusive gallhonorna. I den sista studien, IV, studerades sambandet 
mellan avelsresultatet och antikroppsmängden i DBS. I den första delen av 
studien analyserades avelsresultatet och antikroppsmängden för 2067 
förstaårshonor och äldre avelshonor från en gård. Den studerade gården hade 31 
% gallhonor och en genomsnittlig kullstorlek på 5,2 valpar per valpad hona 
(motsvarande 3,6 valpar per parad hona). Det var stora skillnader i antalet 
minkhonor hade en hög antikroppsmängd och därmed klassades som 
plasmacytossjuka. Totalt klassades 73 % av förstaårshonorna och 48 % av de 
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äldre honorna som sjuka. Denna skillnad var även tydlig i avelsresultatet – 
förstaårshonorna hade en genomsnittlig kullstorlek på 5,0 valpar per valpad hona 
med en gallprocent på 45 % (motsvarande 2,3 valpar per parad hona) medan de 
äldre honorna hade en genomsnittlig kullstorlek på 5,2 per valpad hona och en 
gallprocent på 17 % (motsvarande 4,3 valpar per parad hona). Risken för att bli 
gallhona var generellt högre för förstaårshonor än äldre honor oavsett 
antikroppsmängd men det var en större risk för förstaårshonorna som klassats 
som plasmacytossjuka att bli gallhona jämfört med förstaårshonor som inte 
klassats som plasmacytossjuka. För de äldre honorna kunde däremot ingen 
statistiskt säkerställd skillnad ses i avelsresultat mellan plasmacytossjuka och 
friska honor. Även minkens färg spelade roll för risken att bli gallhona med en 
något högre risk för Hedlund-vita minkhonor än bruna minkhonor oavsett 
antikroppsmängd. För kullstorleken per valpad hona så kunde inget samband 
med antikroppsmängden statistiskt säkerställas i den här delen av studien. 
Åldern hos minkhonan hade en signifikant betydelse för kullstorleken även om 
den effekten var liten; medelkullstorleken hos äldre honor var ungefär 5 % större 
än medelkullstorleken hos förstaårshonorna.  
I den andra delen av IV analyserades avelsresultatet och antikroppsmängden 
för 10 368 förstaårshonor från fyra gårdar. De fyra gårdarna hade i genomsnitt 
14 % gallhonor och en genomsnittlig kullstorlek på 5,9 valpar per valpad hona 
(motsvarande 5,1 valpar per parad hona). Det var stora skillnader i antalet honor 
som kategoriserades som plasmacytossjuka på de olika gårdarna, med en 
variation från 8% till 51 %. Denna skillnad sågs till viss del även i avelsresultatet 
där gallprocenten varierade mellan 14 – 19 % och den genomsnittliga 
kullstorleken varierade mellan 5,6 och 6,1 valpar per valpad hona. 
Sammanfattningsvis hade plasmacytossjuka honor högre risk för att gå gall och 
hade i genomsnitt färre valpar per valpad hona jämfört med friska honor. Även 
minkhonans färg och i från vilken gård hon kom från hade betydelse för det 
slutliga avelsresultatet.  
I den här avhandlingen illustreras sambandet mellan minkhonans 
antikroppsmängd och avelsresultatet vidare. Istället för att dela in minkhonorna 
i sjuk och frisk delades minkhonorna in i tre olika kategorier beroende på deras 
antikroppsmängd: frisk, sjuk+ och sjuk++. Minkhonorna som klassificerades som 
sjuk+ hade en 1,4 gånger större risk att bli gallhonor men ingen påvisbar 
påverkan på kullstorleken per valpad hona; minkhonor som klassificerades som 
sjuka++ hade 2,3 gånger större risk att bli gallhonor och fick i genomsnitt 11 % 
färre valpar per valpad hona jämfört med de friska honorna. Genom att 
kategorisera minkhonorna i tre olika kategorier så är ett kontrollprogram för AD 
möjligt även på gårdar med hög förekomst av plasmacytos.  
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Utvärdering av ELISA-systemet baserat på VP2 antigen visade att testet kan 
användas för att mäta antikroppar i både serum och DBS med hög tillförlitlighet 
och antikroppsmängden i DBS kan även användas för att hitta minkar med 
förhöjd nivå av gammaglobuliner i blodet. Detta test kan därför användas för att 
välja ut minkonor för avel som kan förväntas att hålla sig friska. Att kunna avla 
på individer som förväntas hålla sig friska säkrar bibehållen välfärd hos 
minkarna, minskar risken för negativ påverkan på avelsresultatet och kan 
förväntas leda till en förbättrad produktionsekonomi i områden med endemisk 
AD. Rent praktiskt kan en strategi för bekämpning av AD baseras på att 
identifiera plasmacytossjuka djur på gården med hjälp av djurens 
antikroppsmängd i februari. På gårdar där en hög andel djur har en hög 
antikroppsmängd är det inte realistiskt att välja bort alla djur med höga 
antikroppsnivåer i en snabb process. På dessa gårdar finns möjligheten att dela 
upp djuren i ytterligare kategorier för att underlätta urvalet av avelsdjur och på 
så vis arbeta långsiktigt för en gradvis förbättrad plasmacytosstatus på gården i 
samklang med andra kriterier för urval av avelsdjur. 
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